clopidogrel and Atrial Fibrillation

clopidogrel has been researched along with Atrial Fibrillation in 240 studies

Research

Studies (240)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (1.25)	18.2507
2000's	63 (26.25)	29.6817
2010's	150 (62.50)	24.3611
2020's	24 (10.00)	2.80

Authors

Authors	Studies
Chen, X; Cui, YK; Dong, JZ; Du, X; Feng, L; He, L; Hu, R; Jia, CQ; Li, X; Long, DY; Lv, WH; Ma, CS; Ning, M; Sang, CH; Tang, RB	1
Andreev, D; Baturina, O; Bochkov, P; Fedina, L; Grishina, E; Ivashchenko, D; Mirzaev, K; Ryzhikova, K; Shevchenko, R; Sychev, D	1
Devine, B; Hendrix, N; Jiang, S; Malone, D; Mathias, PC; Shirts, BH; Tarczy-Hornoch, P; Veenstra, D	1
Ge, T; Song, EJ; Tang, S; Wang, J; Zhou, W; Zhu, Z	1
Alexopoulos, D; Benetou, DR; Dragona, VM; Kanakakis, I; Kintis, K; Lianos, I; Mantis, C; Patsilinakos, S; Sionis, D; Varlamos, C	1
Gu, HQ; Jiang, Y; Li, H; Li, ZX; Liu, LP; Meng, X; Wang, CJ; Wang, YJ; Wang, YL; Yang, X; Zhang, XM; Zhao, XQ	1
Berteotti, M; Ciardetti, N; Di Mario, C; Fortini, A; Giusti, B; Gori, AM; Grossi, G; Lotti, E; Marchionni, N; Marcucci, R; Migliorini, A; Valenti, R	1
Bai, J; Chen, Y; Dong, P; Gong, X; Hua, R; Ke, Y; Li, C; Liu, K; Wang, Q; Wang, X; Wu, T; Xiao, J; Ying, L; Zhang, B; Zhang, J; Zhang, W; Zhang, X; Zhu, L	1
Asano, T; Fukushima, K; Harada, J; Hiraga, T; Ishio, N; Kanda, J; Kitahara, H; Kobayashi, T; Kobayashi, Y; Kuriyama, N; Matsumoto, T; Miyahara, H; Ohno, Y; Okino, S; Sakamoto, N; Sano, M; Sato, T; Suzuki, S; Uchiyama, R; Yamamoto, M; Yamashita, D; Yamazaki, T	1
Farag, A; Hamabe, L; Mandour, AS; Matsumoto, K; Tanaka, R; Uemura, A; Yoshida, T	1
Grajek, S; Michalak, M; Olasińska-Wiśniewska, A; Ritter, SS	1
Açıkel, S; Aker, M; Algül, E; Çimen, T; Dural, M; Erat, M; Felekoğlu, MA; Guliyev, İ; Sunman, H; Tulmaç, M	1
Airaksinen, KEJ; Biancari, F; Jaakkola, S; Lund, J; Pouru, JP; Saraste, A	1
Abdel-Wahab, M; Arnold, M; Balan, P; Blanke, P; Dangas, GD; De Backer, O; Guimarães, AHC; Jeger, RV; Jilaihawi, H; Kim, WK; Kini, AS; Kofoed, KF; Leipsic, JA; Makkar, R; Mathiassen, ON; Mehran, R; Nørgaard, BL; Søndergaard, L; Terkelsen, CJ; Van Mieghem, N; Veien, KT; Windecker, S	1
Baldus, S; Dangas, GD; De Backer, O; Gilard, M; Giustino, G; Guimarães, AHC; Gullestad, L; Herrmann, HC; Kini, A; Mack, M; Makkar, RR; Mehran, R; Möllmann, H; Moreno, R; Schäfer, U; Seeger, J; Søndergaard, L; Tchétché, D; Thomitzek, K; Tijssen, JGP; Valgimigli, M; van Amsterdam, RGM; Volkl, AA; von Lewinski, D; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Wöhrle, J; Zazula, A	1
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Jansky, P; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Seung, KB; Steg, PG; Ten Berg, JM; Zateyshchikov, DA	1
Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Maeng, M; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Liao, YWB; Wang, TKM	1
Bhatt, DL; Cannon, CP; de Veer, A; Hohnloser, SH; Kimura, T; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Berry, NC; Bhatt, DL; Cannon, CP; Hohnloser, SH; Kimura, T; Lip, GYH; Mauri, L; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Darius, H	1
Boccuzzi, G; Brscic, E; Casu, G; Colombo, A; Golino, P; Mangieri, A; Pagnotta, PA; Pasceri, V; Patti, G; Rapacciuolo, A; Russo, V; Sticchi, A; Verolino, G; Vizzi, V	1
Casula, M; Fabris, F; Ferlini, M; Fortuni, F; Leonardi, S; Oltrona Visconti, L	1
Camaj, A; Giustino, G; Halperin, JL; Miller, MS	1
An, X; Liu, Y; Liu, YJ; Lv, H; Niu, XH; Tan, R; Xia, YL; Yang, X; Yin, X	1
Bhatt, DL; Cannon, CP; Costa, F; Hohnloser, SH; Lip, GYH; Miede, C; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Valgimigli, M	1
Akao, M; Ako, J; Hagiwara, N; Hirayama, A; Kaikita, K; Kimura, K; Matoba, T; Matsui, K; Miyauchi, K; Nakamura, M; Ogawa, H; Yasuda, S	1
Agudo-Fernández, S; Calvo Morillas, I; Castaño Milla, C; González Blanco, A; Olmos Jerez, JA; Sancho Del Val, L	1
Belmin, J; Jarzebowski, W; Lafuente-Lafuente, C; Melkonian, M; Pautas, E; Siguret, V	1
Bhatt, DL; Grove, EL; Kristensen, SD; Pareek, M; Ten Berg, JM	1
Ahn, JM; Choi, HI; Kang, SH; Kang, SJ; Kim, YH; Lee, CW; Lee, PH; Lee, SW; Park, DW; Park, SJ; Park, SW	1
Bang, CS; Hong, KS; Hong, MK; Jeong, H; Jung, MH; Kim, CY; Park, SM	1
Huang, RC; Yuan, C; Zhong, L	1
Bhatt, DL; Cannon, CP; Ellis, SG; Gropper, S; Harper, R; Hohnloser, SH; Januzzi, JL; Kimura, T; Kleine, E; Lip, GYH; Maeng, M; Manassie, J; Merkely, B; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM; Zeymer, U	1
Lim, GB	1
Berger, JS; Bjerring Olesen, J; Gerds, TA; Gislason, GH; Hansen, ML; Lamberts, M; Langtved Pallisgaard, J; Nissen Bonde, A; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C	1
Bliden, KP; Gurbel, PA; Tantry, US; Venkataraman, G	1
Becher, PM; Blankenberg, S; Fluschnik, N; Schnabel, R; Westermann, D	1
Bonello, L; Camoin-Jau, L; Gaubert, M; Laine, M; Paganelli, F; Resseguier, N	1
Benavente, O; Connolly, SJ; Hart, RG; Pearce, LA; Perera, KS; Sharma, M	1
Czub, P; Fojt, A; Grygier, M; Hendzel, P; Kapłon-Cieślicka, A; Karolczak, N; Kochman, J; Lodziński, P; Maksym, J; Marchel, M; Mazurek, T; Opolski, G; Piątkowski, R; Wilimski, R	1
Chan, PH; Kwok, OH; Lam, CC; Lam, YY; Siu, CW; Wong, CK	1
Bologna, F; Bordignon, S; Chen, S; Chun, KRJ; Konstantinou, A; Nagase, T; Perrotta, L; Schmidt, B; Weise, FK	1
Benit, E; Bertrand, PB; Habran, M; Kenis, K; Lecomte, J; Moonen, L; Stroobants, D	1
Bode, C; Brachmann, J; Darius, H; Duerschmied, D; Frey, N; Katus, HA; Rottbauer, W; Schäfer, A; Thiele, H; Zeymer, U	1
Fredgart, M; Gill, S	1
Gao, Y; Hu, C; Liu, Y; Luo, Y; Wang, X; Zhang, X; Zhao, X; Zhou, H	1
Huang, J; Liu, L; Tang, X; Zhang, X	1
Carlsen, SM; Giannadakis, C; Gulati, AM; Gulati, S; Jakola, AS; Jensberg, H; Madsbu, MA; Salvesen, Ø; Solheim, O; Øie, LR	1
Colivicchi, F; Falaschi, G; Tubaro, M	1
Berger, JS; Gislason, GH; Lamberts, M; Lock Hansen, M; Nissen Bonde, A; Olesen, JB; Pallisgaard, JL; Sindet-Pedersen, C; Staerk, L; Torp-Pedersen, C	1
Andreotti, F; Calò, L; Crea, F; D'Amario, D; Della Bona, R; Galli, M; Porto, I; Savarese, G; Vergallo, R	1
Brockmeyer, M; Dannenberg, L; Helten, C; Hohlfeld, T; Kelm, M; Konsek, D; Levkau, B; M'Pembele, R; Mourikis, P; Naguib, D; Polzin, A; Schulze, V; Trojovsky, K; Wolff, G; Zako, S; Zeus, T	1
Argyriou, C; Georgakarakos, EI; Georgiadis, GS; Koutsoumpelis, A; Tasopoulou, KM	1
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kleine, E; Lip, GYH; Nordaby, M; Oldgren, J; Steg, PG; Ten Berg, JM	1
Bhatt, DL; Brueckmann, M; Cannon, CP; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GYH; Mauri, L; Miede, C; Montalescot, G; Nordaby, M; Oldgren, J; Ozkor, M; Steg, PG; Ten Berg, JM; Vardas, P	1
Angiolillo, DJ; Kalkman, DN; Mehran, R	1
Benatti, G; Bosi, D; Cattabiani, MA; Cozza, F; Guidorossi, A; Lina, D; Menozzi, A; Vignali, L	1
Dimmitt, SB; Ferner, RE; Floyd, CN	1
Green, JB; Guimarães, PO; Holman, RR; Lokhnygina, Y; Lopes, RD; McGuire, DK; Peterson, ED; Stevens, SR	1
de Potter, T; Dujka, L; Jiresova, E; Lekesova, V; Neuzil, P; Reddy, VY; Rensing, B; Tromp, SC; van der Heyden, J	1
Honda, T; Horie, K; Inoue, N; Isawa, T; Kato, S; Matsumoto, T; Mizutani, Y; Ootomo, T; Osai, N; Tada, N; Taguri, M	1
Chen, S; Gao, X; Ge, Z; Kong, X; Wang, F; Wang, Z; Zhang, J; Zuo, G	1
Kowacs, PA; Macuco, ALB; Nascimento, MTMS; Rizelio, V; Sato, HK; Souza, RKM	1
Benz, AP; Beresh, H; Conen, D; Connolly, SJ; Healey, JS; Masiero, S; McIntyre, WF; Wang, J; Wong, JA	1
Gloekler, S; Khattab, AA; Krause, R; Meier, B; Nietlispach, F; Schmid, M; Shakir, S; Wenaweser, P; Windecker, S	1
Stiefelhagen, P	3
Ağırbaşlı, M; Tanrıkulu, A	1
Christensen, CB; Gislason, GH; Hansen, ML; Kristensen, SL; Køber, L; Lamberts, M; Lip, GY; Mikkelsen, A; Olesen, JB; Schjerning Olsen, AM; Torp-Pedersen, C	1
Apostolakis, S; Lip, GY; Shantsila, E	1
Abdel-Wahab, M; Akin, I; El-Mawardy, M; Geist, V; Richardt, G; Seivani, Y; Sulimov, DS; Toelg, R	1
Ansell, J; Chang, P; Ezekowitz, MD; Fonarow, GC; Gersh, B; Go, AS; Hylek, E; Kim, S; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Singer, DE; Steinberg, BA; Thomas, L	1
McCormack, T	1
Ahn, T; Choi, H; Choi, IS; Han, SH; Kang, WC; Lee, K; Moon, CI; Oh, PC; Shin, EK; Suh, SY	1
He, B; Kun, L; Liu, X; Wu, B	1
Becker, RC; Breithardt, G; Califf, RM; Fox, KA; Goodman, SG; Hacke, W; Halperin, JL; Hankey, GJ; Mahaffey, KW; Nessel, CC; Patel, MR; Piccini, JP; Singer, DE; Stevens, SR; White, HD	1
Araki, T; Enomoto, Y; Hara, H; Hori, M; Iijima, R; Itaya, H; Ito, N; Nagashima, Y; Nakamura, M; Shiba, M; Sugi, K; Tokue, M; Utsunomiya, M; Yamazaki, K	1
Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Lassen, JF; Lip, GY; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C	1
Airaksinen, KE; Biancari, F; Karjalainen, PP; Kirchhof, P; Kiviniemi, T; Laine, M; Lip, GY; Niemelä, M; Rubboli, A; Schlitt, A; Valencia, J; Vikman, S	1
Gnall, EM; Ice, DS; Kowey, PR; Shapiro, TA	1
Alpert, JS; Asencio, LA; Huang, JJ	1
Burke, DT; Lee, J	1
Cervera, A; Llull, L; Martín, V; Vidal, B	1
Thompson, PL; Verheugt, FW	1
Adriaenssens, T; Dewilde, WJ; Hansen, ML; Janssen, PW; Lamberts, M; Storey, RF; Ten Berg, JM; Verheugt, FW	1
Cairns, JA; Connolly, S; Cox, JL; Dorian, P; Gladstone, D; Healey, JS; Ivers, N; Leblanc, K; Macle, L; McMurtry, MS; Mitchell, LB; Nattel, S; Stiell, IG; Verma, A	1
Judkins, C; Thompson, AG; Thompson, PL	1
Bico, B; Braun, OÖ; Chaudhry, U; Gustav Smith, J; Jovinge, S; Koul, S; Scherstén, F; Svensson, PJ; Tydén, P; van der Pals, J; Wagner, H	1
Bakheet, MF; Hart, RG; Pearce, LA	1
Chen, L; Fu, C; Lu, W; Ma, G; Wang, Y; Yao, Y; Zuo, P	1
Connolly, SJ; Hart, RG; Healey, JS; Hohnloser, SH; McAlister, FA; Pfeffer, MA; Sandhu, RK; Yuan, F; Yusuf, S	1
Hayashi, K; Horie, N; Izumo, T; Kaminogo, M; Nagata, I; Tsujino, A	1
Angoulvant, D; Bejan-Angoulvant, T; Fauchier, L; Ivanes, F; Lip, GYH; Saint Etienne, C; Villejoubert, O	1
Bode, C; Cohen, M; Fox, K; Gibson, CM; Halperin, J; Husted, S; Lip, GY; Mehran, R; Peterson, E; van Eickels, M; Verheugt, F; Wildgoose, P	1
Kalogeras, K; Kariori, M; Kolokathis, AM; Lavda, M; Moldovan, C; Mpei, E; Siasos, G; Tousoulis, D; Vavuranakis, M; Vrachatis, D	1
Gao, F; Liu, XL; Shen, H; Wang, ZJ; Yang, SW; Zhou, YJ	1
Blann, AD; Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F	1
Agewall, S; Huber, K; Lip, GY; Rubboli, A	1
Hwang, JC; Jun, JH	1
Elis, A; Lishner, M; Pereg, D; Yahia, DH	1
Fiedler, AK; Kastrati, A; Martischnig, AM; Massberg, S; Mayer, K; Mehilli, J; Petzold, T; Pollak, J; Sarafoff, N; Schulz-Schüpke, S; Sibbing, D	1
Di Pasquale, G; Rubboli, A	1
Ang, ES; De Silva, DA; Fabiaña, N; Ramaswami, AP	1
Bonnet, JL; Cuisset, T; Pankert, M; Salaun, E	1
D'Ancona, G; Ince, H; Ketterer, U; Kische, S; Ortak, J; Siegel, I	1
Ansell, J; Chang, P; Fonarow, GC; Gersh, BJ; Go, AS; Hylek, EM; Kowey, P; Lopes, RD; Mahaffey, KW; Peterson, ED; Piccini, JP; Rao, M; Simon, DN; Singer, DE; Thomas, L	1
Alfonso, F; Alonso, A; Barrabés, JA; Bueno, H; Cequier, A; García Del Blanco, B; García-Dorado, D; Mutuberría, M; Rodríguez-Leor, O; Sambola, A; Tornos, P; Zueco, J	1
Akehurst, RL; Amorosi, SL; Armstrong, SO; Brereton, N; Hertz, DS; Holmes, DR; Reddy, VY	1
Chen, KY; Li, G; Liu, T; Xu, G; Zhang, N; Zhao, J	1
Agarwal, S; Barakat, AF; Chaudhury, P; Ellis, SG; Faza, NN; Kapadia, SR; Mentias, A; Murat Tuzcu, E; Parashar, A; Wayangankar, S	1
Aonuma, K; Gosho, M; Hoshi, T; Nogami, A; Sato, A	1
Armstrong, PW; Bhatt, DL; Corbalán, R; Cyr, DD; Fox, KA; Jackson, LR; Lopes, RD; Lüscher, TF; Magnus Ohman, E; Martinez, F; Neely, ML; Piccini, JP; Prabhakaran, D; Roe, MT; White, HD; Winters, KJ	1
Bordignon, S; Chun, JK; Dugo, D; Fürnkranz, A; Konstantinou, A; Perrotta, L; Schmidt, B	1
Fahed, E; Ghauche, J; Maarrawi, J; Menassa-Moussa, L; Moussa, R; Nohra, G; Okais, N; Rahme, R; Rizk, T; Samaha, E	1
Buck, J; Cram, P; Gage, BF; Kaboli, P; Vaughan Sarrazin, MS	1
Ärnlöv, J; Carlsson, AC; Holzmann, M; Johansson, SE; Sundquist, J; Sundquist, K; Wändell, P	1
Combes, N; Dinet, ML; Iriart, X; Jalal, Z; Pillois, X; Renou, P; Sibon, I; Thambo, JB	1
Amstalden, H; Beer, JH; Benussi, S; Bonetti, NR; Breitenstein, A; Camici, GG; Falk, V; Glanzmann, M; Holy, EW; Keller, S; Lüscher, TF; Maisano, F; Reiner, MF; Savarese, G; Stämpfli, SF; Steffel, J	1
Airaksinen, KE; Buerke, M; Eeckhout, E; Freedman, SB; Gershlick, AH; Halperin, JL; Lip, GY; Rubboli, A; Schlitt, A; Tse, HF; Verheugt, FW	1
Cambronero, F; Caro, C; Garrido, IP; Lip, GYH; Manzano-Fernández, S; Marín, F; Pascual-Figal, DA; Pastor, FJ; Pinar, E; Valdés, M	1
Bond, SP; Buerke, M; Faerber, J; Maegdefessel, L; Messow, CM; Muenzel, T; Raaz, U; Schlitt, A; Weiss, C; Werdan, K	1
Commerford, P; Connolly, SJ; Eikelboom, J; Flaker, G; Franzosi, MG; Healey, JS; Pogue, J; Yusuf, S	1
Chrolavicius, S; Connolly, SJ; Hart, RG; Hohnloser, SH; Pfeffer, M; Pogue, J; Yusuf, S	1
Go, AS	1
Boysen, G	1
Preobrazhenskiĭ, DV	2
Hoppe, UC	1
Einecke, D	1
Verheugt, FW	3
Crijns, HJ; Dinh, T; Pisters, R	1
Chua, D; Legal, M; Shalansky, SJ	1
DeZee, KJ; Lee, YE	1
Goldstein, LB	1
Butaffuoco, F; Richard, T; Vanhaeverbeek, M	1
Pangtey, GS; Shalimar, S; Singh, KK	1
Bhatt, DL; Cannon, CP; Depta, JP; Fonarow, GC; Peacock, WF; Zhao, X	1
Chen, CP; Seet, RC	1
Healey, JS	1
Apostolakis, S; Lane, DA; Lip, GY; Shantsila, E	1
Lee, TH	1
Bremerich, J; Christ, M; Wandeler-Meyer, K	1
Di Sciascio, G; Irini, D; Pasceri, V; Patti, G; Pelliccia, F; Pristipino, C; Roncella, A; Speciale, G; Varveri, A	1
Böhm, M; Dichgans, M; Diener, HC; Endres, M; Grond, M; Hacke, W; Hoppe, UC; Kirchhof, P; Laufs, U; Meinertz, T; Ringelstein, EB; Rosenkranz, S; Röther, J	1
Gao, F; Jia, de A; Liu, XL; Nie, B; Shen, H; Wang, ZJ; Yan, ZX; Yang, SW; Yu, M; Zhou, YJ	1
Azuma, J; Maegdefessel, L; Tsao, PS	1
Eikelboom, JW; Mehta, SR; Paikin, JS	1
Achkar, A; Conard, J; Horellou, MH; Samama, MM	1
Budaj, A; Chrolavicius, S; Connolly, SJ; De Caterina, R; Morais, J; Pogue, J; Renda, G; Yusuf, S	1
Abildstrøm, SZ; Andersen, SS; Clausen, MT; Fog-Petersen, ML; Folke, F; Gadsbøll, N; Gislason, GH; Hansen, ML; Køber, L; Poulsen, HE; Raunsø, J; Schramm, TK; Sørensen, R; Torp-Pedersen, C	1
Schlitt, A	1
Anand, SS; Bhatt, DL; Connolly, SJ; Eikelboom, JW; Fox, KA; Hirsh, J; Mehta, SR; Paré, G; Simonsen, K; Yusuf, S	1
Hankey, GJ	2
Bigalke, B; Geisler, T; Schwab, M	1
Smetana, GW; Srour, JF	1
Kamal, AK; Khan, M	2
Green, A; Sauder, M; Ziegelstein, RC	1
Hart, RG	1
Flaker, G; Garg, N; Rajpurohit, N	1
Clem, JR	1
Bhattacharya, P; Chaturvedi, S	1
Bushnell, CD; Lopes, RD; Olson, DM; Pan, W; Peterson, ED; Shah, BR; Zhao, X	1
Ana, G; António, F; Cardona, L; Cruz, FR; Leal, A; Lídia, S; Luísa, B	1
Arias-Rivas, S; Blanco, M; Castillo, J; Fernández-Ferro, J; Leira, R; Rodríguez-Yáñez, M	1
Gammack, JK; Messinger-Rapport, BJ; Morley, JE; Thomas, DR	1
Connolly, SJ; de Caterina, R; Eikelboom, JW; Hart, RG; Hirsh, J; Hohnloser, S; Ng, J; Pogue, J; Yusuf, S	1
Fang, MC	1
Almadi, MA; Barkun, A; Brophy, J	1
Antonijevic, N; Asanin, M; Kocev, N; Krljanac, G; Lasica, R; Marinkovic, J; Mrdovic, I; Ostojic, M; Perunicic, J; Savic, L; Vasiljevic, Z	1
Anglade, MW; Coleman, CI; Kluger, J; Sobieraj, DM; Straznitskas, AD	1
Ghaswalla, PK; Harpe, SE; Slattum, PW	1
Afanas'eva, EV; Belousov, DIu; Belousov, IuB; Iavelov, IS; Mareev, VIu	1
Eckman, MH; Fang, MC; Go, AS; Halperin, JL; Howard, PA; Hughes, M; Hylek, EM; Lane, DA; Lip, GYH; Manning, WJ; Schulman, S; Singer, DE; Spencer, FA; You, JJ	1
Anand, SS; Connolly, SJ; Eikelboom, JW; Fox, KA; Mehta, SR; Paré, G; Ross, S; Yusuf, S	1
Agarwal, S; Hachamovitch, R; Menon, V	1
Airaksinen, KE; Biancari, F; Karjalainen, P; Kiviniemi, T; Niemelä, M; Pietilä, M; Puurunen, M; Vikman, S; Ylitalo, A	1
Lewis, JP; Shuldiner, AR	1
Alexander, KP; Fosbol, EL; Klaskala, W; Li, S; Lopes, RD; Mills, RM; Peterson, ED; Piccini, JP; Roe, MT; Shah, B; Thomas, L; Wang, TY	1
Halperin, JL; Varughese, CJ	1
Petrie, C	1
Alexander, KP; Foody, JM; Funk, M; Granger, CB; Li, L; Lopes, RD; Peterson, ED; Wang, TY	1
Kanorskiĭ, SG; Shevelev, VI	1
Gislason, GH; Hansen, CM; Hansen, ML; Karasoy, D; Kristensen, SL; Køber, L; Lamberts, M; Olesen, JB; Ruwald, MH; Torp-Pedersen, C	1
de Caterina, R; Renda, G	1
Rao, SV; Vavalle, JP	1
Crijns, HJ; Pisters, R; Ten Cate, H	1
Connolly, SJ; Coppens, M; Dorian, P; Eikelboom, JW; Hart, RG; Lip, GY; Shestakovska, O; Yusuf, S	1
Alexander, JH; Alexander, KP; Broderick, S; Granger, CB; Hess, CN; Lopes, RD; Mahaffey, KW; Newby, LK; Peterson, ED; Piccini, JP; Shaw, LK	1
Kozan, Ö	1
Kanorsky, SG; Shevelev, VI	1
Azoulay, L; Dell'Aniello, S; Renoux, C; Simon, T; Suissa, S	1
Buchbinder, M; Doshi, SK; Halperin, JL; Holmes, D; Huber, K; Neuzil, P; Reddy, VY; Sievert, H	1
Blann, AD; Chin, BS; Kamath, S; Lip, GY	1
Meyer, BJ	1
Connolly, SJ	1
McConn Walsh, R; Watters, K	1
Bandh, S; Job, B; Lidell, C; Lindell, P; Svedberg, LE; Wallentin, L	1
Connolly, SJ; Hohnloser, SH	1
Barry, WH; Coletti, AT; Jessup, DB; Muhlestein, JB; Shean, FC; Whisenant, BK	1
Cooper, HA	1
Di Micco, B; Di Micco, G; Di Micco, P; Niglio, A; Romano, M	1
Lip, GY; Tan, KT	1
Cocci, F; De Caterina, R; Lazzerini, G; Lorenzoni, R	1
Waldo, AL	1
Bereznicki, LR; Jackson, SL; Peterson, GM	1
Hart, RG; Pearce, LA; Tonarelli, SB	1
de Paola, AA; Veloso, HH	1
Hacke, W	1
Boccara, F; Cohen, A; Ederhy, S; Hammoudi, N; Janower, S; Meuleman, C	1
Szapáry, L	1
Steinbeck, G	1
Chrolavicius, S; Connolly, S; Hart, R; Hohnloser, S; Pfeffer, M; Pogue, J; Yusuf, S	1
Anand, I; Arthur, H; Avezum, A; Bethala-Sithya, M; Blumenthal, M; Budaj, A; Camm, J; Ceremuzynski, L; Chrolavicius, S; Commerford, PJ; Connolly, S; De Caterina, R; Diaz, R; Flaker, G; Flather, M; Fox, KA; Frangin, G; Franzosi, MG; Gaudin, C; Goldhaber, S; Golitsyn, S; Granger, C; Halon, D; Hart, R; Hermosillo, A; Hohnloser, S; Hunt, D; Jansky, P; Joyner, C; Karatzas, N; Keltai, M; Lanas, F; Lau, CP; Le Heuzey, JY; Lewis, BS; Morais, J; Morillo, C; Oto, A; Paolasso, E; Peters, RJ; Pfeffer, M; Pfisterer, M; Piegas, L; Pipillis, T; Proste, C; Sitkei, E; Swedberg, K; Synhorst, D; Talajic, M; Trégou, V; Valentin, V; van Mieghem, W; Varigos, J; Weintraub, W; Yusuf, S	1
Gilard, M; Helft, G; Le Feuvre, C; Zaman, AG	1
Karpha, M; Lip, GY	1
Cheng, Hy	1
Andrel, J; Chervoneva, I; DeCaro, M; DeEugenio, D; Duong, P; Greenspon, A; Kolman, L; Lam, L; Lee, G; McGowan, C; Ruggiero, N; Singhal, S	1
Meinertz, T	1
De Caterina, R; Renda, G; Zimarino, M	1
Arnau, MA; Aznar, JA; Cabrera, N; Casaña, P; Cid, AR; Haya, S; Rueda, J; Zorio, E; Zúñiga, P	1
Lip, GY	1
Connolly, SJ; Healey, JS; Hohnloser, SH; Pajitnev, D; Pfeffer, MA; Pogue, J; Yusuf, S	1
Cairns, JA; Gent, M; Hirsh, J; Marler, J; Pogue, J; Pritchett, EL; Wittes, J; Wyse, DG	1
Berger, PB; Bhatt, DL; Fox, KA; Hacke, W; Hankey, GJ; Hart, RG; Hu, T; Topol, EJ	1
Connolly, SJ; De Caterina, R; Flaker, G; Hart, RG; Healey, JS; Hohnloser, SH; Pfeffer, MA; Pogue, J; Yusuf, S	1
Bogousslavsky, J; Dewarrat, A	1
Ferguson, JJ; Gonzalez, ER; Kannel, WB; Olin, JW; Raps, EC	1
Dyken, ML	1
Lalouschek, W; Lang, W; Müllner, M	1

Reviews

51 review(s) available for clopidogrel and Atrial Fibrillation

Article	Year
Triple versus double antithrombotic therapy in patients with atrial fibrillation and stent implantation: a meta‑analysis of randomized trials. Kardiologia polska, 2019, Sep-23, Volume: 77, Issue:9 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Stents; Thrombosis; Treatment Outcome	2019
Antithrombotic regimen for patients with cardiac indication for dual antiplatelet therapy and anticoagulation: a meta-analysis of randomized trials. Coronary artery disease, 2020, Volume: 31, Issue:3 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Factor Xa Inhibitors; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Ticagrelor; Warfarin	2020
Meta-Analysis Comparing Potent Oral P2Y American journal of cardiovascular drugs : drugs, devices, and other interventions, 2021, Volume: 21, Issue:2 Topics: Aged; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic	2021
Antithrombotic Therapy in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. Cardiology clinics, 2020, Volume: 38, Issue:4 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Purinergic P2Y Receptor Antagonists	2020
Bleeding risk of antiplatelet drugs compared with oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-analysis. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:7 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin	2017
Antithrombotic strategies for preventing long-term major adverse cardiovascular events in patients with non-valvular atrial fibrillation who undergo percutaneous coronary intervention. Expert opinion on pharmacotherapy, 2017, Volume: 18, Issue:9 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Recurrence; Ticlopidine	2017
[Impact of different antithrombotic therapy strategy on prognosis in coronary heart disease patients combining with atrial fibrillation: a meta analysis]. Zhonghua xin xue guan bing za zhi, 2017, Jun-24, Volume: 45, Issue:6 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prognosis; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Warfarin	2017
Antithrombotic therapy: Dual therapy after PCI in AF. Nature reviews. Cardiology, 2017, Volume: 14, Issue:11 Topics: Antithrombins; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Purinergic P2Y Receptor Antagonists; Thromboembolism	2017
Antithrombotic therapy in patients with non-valvular atrial fibrillation undergoing percutaneous coronary intervention: should we change our practice after the PIONEER AF-PCI and RE-DUAL PCI trials? Clinical research in cardiology : official journal of the German Cardiac Society, 2018, Volume: 107, Issue:7 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clopidogrel; Drug Administration Schedule; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Treatment Outcome	2018
Efficacy and safety of triple therapy versus dual antiplatelet therapy in patients with atrial fibrillation undergoing coronary stenting: A meta-analysis. PloS one, 2018, Volume: 13, Issue:6 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Drug-Related Side Effects and Adverse Reactions; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hypertension; Male; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk Factors; Stents; Stroke; Thrombosis; Warfarin	2018
[Antithrombotic therapy in patients with atrial fibrillation and acute coronary syndrome]. Giornale italiano di cardiologia (2006), 2018, Volume: 19, Issue:10 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Thrombosis	2018
Dropping aspirin in patients with atrial fibrillation undergoing percutaneous coronary intervention: a jump with a weak parachute? European heart journal. Cardiovascular pharmacotherapy, 2019, 01-01, Volume: 5, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Decision-Making; Clopidogrel; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; Meta-Analysis as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Treatment Outcome	2019
Novel Oral Anticoagulants in Peripheral Artery Disease: Current Evidence. Current pharmaceutical design, 2018, Volume: 24, Issue:38 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Hemorrhage; Humans; Peripheral Arterial Disease; Treatment Outcome	2018
Antithrombotic dose: Some observations from published clinical trials. British journal of clinical pharmacology, 2019, Volume: 85, Issue:10 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Dose-Response Relationship, Drug; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Warfarin	2019
Clinical Outcomes of Antithrombotic Strategies for Patients with Atrial Fibrillation After Percutaneous Coronary Intervention. International heart journal, 2019, May-30, Volume: 60, Issue:3 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Observational Studies as Topic; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Vitamin K	2019
Triple therapy (aspirin, clopidogrel and oral anticoagulant) after percutaneous coronary intervention: another call for personalized medicine. Anadolu kardiyoloji dergisi : AKD = the Anatolian journal of cardiology, 2013, Volume: 13, Issue:5 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Postoperative Complications; Ticlopidine	2013
Pharmacokinetic considerations for antithrombotic therapies in stroke. Expert opinion on drug metabolism & toxicology, 2013, Volume: 9, Issue:10 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Factor Xa; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Factors; Stroke; Tetrazoles; Thiophenes; Thrombin; Ticlopidine; Vitamin K	2013
Unanswered questions in patients with concurrent atrial fibrillation and acute coronary syndrome. The American journal of cardiology, 2014, Mar-01, Volume: 113, Issue:5 Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Morpholines; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Pyrazoles; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiophenes; Thrombosis; Ticlopidine	2014
Combining antiplatelet and antithrombotic therapy (triple therapy): what are the risks and benefits? The American journal of medicine, 2014, Volume: 127, Issue:7 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Warfarin	2014
Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease. Clinical therapeutics, 2014, Sep-01, Volume: 36, Issue:9 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Stroke; Ticlopidine; Vitamin K; Warfarin	2014
Triple therapy for atrial fibrillation and percutaneous coronary intervention: a contemporary review. Journal of the American College of Cardiology, 2014, Sep-23, Volume: 64, Issue:12 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Percutaneous Coronary Intervention; Randomized Controlled Trials as Topic; Ticlopidine; Vitamin K	2014
Effect of addition of clopidogrel to aspirin on subdural hematoma: meta-analysis of randomized clinical trials. International journal of stroke : official journal of the International Stroke Society, 2015, Volume: 10, Issue:4 Topics: Acute Coronary Syndrome; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Hematoma, Subdural; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke, Lacunar; Ticlopidine	2015
Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thrombosis and haemostasis, 2015, Volume: 114, Issue:2 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Clopidogrel; Drug Synergism; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Humans; Mortality; Numbers Needed To Treat; Observational Studies as Topic; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Stroke; Thiazoles; Thrombophilia; Ticlopidine; Vitamin K	2015
New-onset atrial fibrillation after recent coronary stenting: Warfarin or non-vitamin K-antagonist oral anticoagulants to be added to aspirin and clopidogrel? A viewpoint. International journal of cardiology, 2015, Oct-01, Volume: 196 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Combinations; Factor Xa Inhibitors; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stents; Thrombosis; Ticlopidine; Warfarin	2015
Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Annals of medicine, 2008, Volume: 40, Issue:6 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Revascularization; Postoperative Care; Stents; Thrombosis; Ticlopidine; Warfarin	2008
Optimizing antiplatelet therapy in high-risk patients with atrial fibrillation: insights from Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events (ACTIVE A). Stroke, 2009, Volume: 40, Issue:12 Topics: Antihypertensive Agents; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Contraindications; Humans; Irbesartan; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Tetrazoles; Ticlopidine; Treatment Outcome	2009
Modern role for clopidogrel in management of atrial fibrillation and stroke reduction. Vascular health and risk management, 2010, Mar-03, Volume: 6 Topics: Age Factors; Atrial Fibrillation; Clopidogrel; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2010
[New aspects on "triple therapy" after coronary stent implantation]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:41 Topics: Administration, Oral; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk Factors; Stents; Stroke; Thrombosis; Ticlopidine; Vitamin K	2010
Triple therapy in hospitalized patients: facts and controversies. Journal of hospital medicine, 2011, Volume: 6, Issue:9 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hospitalization; Humans; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Thiophenes; Ticlopidine; Warfarin	2011
Clopidogrel hydrogen sulphate for atrial fibrillation. Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:11 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thrombosis; Ticlopidine	2011
New insights in antiplatelet therapy for patients with ischemic stroke. The neurologist, 2011, Volume: 17, Issue:5 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Dipyridamole; Dose-Response Relationship, Drug; Humans; Ischemic Attack, Transient; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2011
[Clopidogrel and stroke]. Revista de neurologia, 2011, Nov-01, Volume: 53, Issue:9 Topics: Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Inflammation; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine	2011
Current trial-associated outcomes with warfarin in prevention of stroke in patients with nonvalvular atrial fibrillation: a meta-analysis. Archives of internal medicine, 2012, Apr-23, Volume: 172, Issue:8 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Brain Ischemia; Clopidogrel; Female; Humans; Incidence; Male; Oligosaccharides; Primary Prevention; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Stroke; Ticlopidine; Treatment Outcome; United States; Warfarin	2012
Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2012, Volume: 35, Issue:1 Topics: Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Practice Guidelines as Topic; Pyrazoles; Pyridines; Pyridones; Risk Assessment; Rivaroxaban; Stroke; Thiazoles; Thiophenes; Thrombolytic Therapy; Ticlopidine; Warfarin	2012
Impact of antiplatelet therapy in heart disease. Advances in cardiology, 2012, Volume: 47 Topics: Acute Coronary Syndrome; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Heart Diseases; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Thromboembolism; Ticlopidine; Treatment Outcome	2012
Bleeding and the use of antiplatelet agents in the management of acute coronary syndromes and atrial fibrillation. Advances in cardiology, 2012, Volume: 47 Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Hemorrhage; Hospital Mortality; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; Risk Assessment; Ticlopidine	2012
Challenges in atrial fibrillation. Advances in cardiology, 2012, Volume: 47 Topics: Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Therapy, Combination; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2012
Preventing stroke in patients with atrial fibrillation: current treatments and new concepts. American heart journal, 2003, Volume: 145, Issue:3 Topics: Aspirin; Atrial Appendage; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Prodrugs; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2003
Combined antiplatelet therapy in atrial fibrillation: review of the literature and future avenues. Journal of cardiovascular electrophysiology, 2003, Volume: 14, Issue:9 Suppl Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Combinations; Evidence-Based Medicine; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Stroke; Thrombosis; Ticlopidine; Treatment Outcome	2003
Trials of newer approaches to anticoagulation in atrial fibrillation. Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing, 2004, Volume: 10 Suppl 1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Thrombin; Ticlopidine; Warfarin	2004
Atrial fibrillation: should we target platelets or the coagulation pathway? Cardiac electrophysiology review, 2003, Volume: 7, Issue:4 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin	2003
Preparing for the post-warfarin generation of antithrombotics. The American journal of managed care, 2004, Volume: 10, Issue:10 Suppl Topics: Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Clopidogrel; Fibrinolytic Agents; Fondaparinux; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Polysaccharides; Prodrugs; Pyridines; Stroke; Ticlopidine	2004
New possibilities in anticoagulant management of atrial fibrillation. Reviews in cardiovascular medicine, 2004, Volume: 5 Suppl 5 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Humans; Oligosaccharides; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin	2004
Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas. Stroke, 2005, Volume: 36, Issue:7 Topics: Administration, Oral; Age Factors; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Pressure; Brain Ischemia; Cerebral Hemorrhage; Clinical Trials as Topic; Clopidogrel; Female; Fibrinolytic Agents; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin	2005
[Preventing cerebrovascular accidents during atrial fibrillation]. Presse medicale (Paris, France : 1983), 2005, Oct-22, Volume: 34, Issue:18 Topics: Administration, Oral; Age Factors; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Azetidines; Benzylamines; Clopidogrel; Drug Therapy, Combination; Electric Countershock; Humans; Hypolipidemic Agents; Incidence; Injections, Subcutaneous; Middle Aged; Oligosaccharides; Placebos; Platelet Aggregation Inhibitors; Prevalence; Prodrugs; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Stroke; Ticlopidine; Warfarin	2005
[Current concepts of the antiplatelet and anticoagulant treatment in the prevention of stroke]. Orvosi hetilap, 2005, Oct-09, Volume: 146, Issue:41 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Delayed-Action Preparations; Dipyridamole; Drug Therapy, Combination; Evidence-Based Medicine; Fibrinolytic Agents; Humans; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Recurrence; Stroke; Ticlopidine; Warfarin	2005
Drug insight: antithrombotic therapy after percutaneous coronary intervention in patients with an indication for anticoagulation. Nature clinical practice. Cardiovascular medicine, 2006, Volume: 3, Issue:12 Topics: Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Heart Valve Prosthesis Implantation; Heparin; Humans; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Venous Thrombosis; Warfarin	2006
Monitoring the ACTIVE-W trial: some issues in monitoring a noninferiority trial. American heart journal, 2008, Volume: 155, Issue:1 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials Data Monitoring Committees; Clopidogrel; Decision Making; Female; Humans; Irbesartan; Male; Prognosis; Randomized Controlled Trials as Topic; Research Design; Risk Assessment; Sensitivity and Specificity; Survival Analysis; Tetrazoles; Ticlopidine; Treatment Outcome	2008
Antiplatelet therapy for stroke prevention. Current atherosclerosis reports, 2007, Volume: 9, Issue:4 Topics: Anticoagulants; Aspirin; Atherosclerosis; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2007
[Antithrombotic agents and prevention of cerebrovascular accidents]. Revue medicale de la Suisse romande, 1996, Volume: 116, Issue:8 Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clopidogrel; Echocardiography; Humans; Intracranial Embolism and Thrombosis; Platelet Aggregation Inhibitors; Primary Prevention; Ticlopidine	1996
Antiplatelet agents and stroke prevention. Seminars in neurology, 1998, Volume: 18, Issue:4 Topics: Aspirin; Atrial Fibrillation; Cerebrovascular Disorders; Clinical Trials as Topic; Clopidogrel; Dipyridamole; Female; Humans; Male; Platelet Aggregation Inhibitors; Ticlopidine	1998

Trials

43 trial(s) available for clopidogrel and Atrial Fibrillation

Article	Year
Rationale and design of the optimal antithrombotic treatment for acute coronary syndrome patients with concomitant atrial fibrillation and implanted with new-generation drug-eluting stent: OPtimal management of anTIthroMbotic Agents (OPTIMA)-4 trial. Clinical cardiology, 2023, Volume: 46, Issue:7 Topics: Acute Coronary Syndrome; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Drug-Eluting Stents; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor	2023
Reduced Leaflet Motion after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 2020, 01-09, Volume: 382, Issue:2 Topics: Aged; Aged, 80 and over; Aortic Valve; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Four-Dimensional Computed Tomography; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement	2020
A Controlled Trial of Rivaroxaban after Transcatheter Aortic-Valve Replacement. The New England journal of medicine, 2020, 01-09, Volume: 382, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Heart Valve Prosthesis; Hemorrhage; Humans; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Thromboembolism; Transcatheter Aortic Valve Replacement	2020
Switching of Oral Anticoagulation Therapy After PCI in Patients With Atrial Fibrillation: The RE-DUAL PCI Trial Subanalysis. JACC. Cardiovascular interventions, 2019, 12-09, Volume: 12, Issue:23 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin	2019
Dabigatran Dual Therapy Versus Warfarin Triple Therapy Post-PCI in Patients With Atrial Fibrillation and Diabetes. JACC. Cardiovascular interventions, 2019, 12-09, Volume: 12, Issue:23 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Diabetes Mellitus; Drug Substitution; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Risk Factors; Ticagrelor; Time Factors; Treatment Outcome; Warfarin	2019
Effect of Lesion Complexity and Clinical Risk Factors on the Efficacy and Safety of Dabigatran Dual Therapy Versus Warfarin Triple Therapy in Atrial Fibrillation After Percutaneous Coronary Intervention: A Subgroup Analysis From the REDUAL PCI Trial. Circulation. Cardiovascular interventions, 2020, Volume: 13, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Dual Anti-Platelet Therapy; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Assessment; Risk Factors; Stents; Thromboembolism; Ticagrelor; Time Factors; Treatment Outcome; Warfarin	2020
Rivaroxaban monotherapy versus combination therapy according to patient risk of stroke and bleeding in atrial fibrillation and stable coronary disease: AFIRE trial subanalysis. American heart journal, 2021, Volume: 236 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Outcome and Process Assessment, Health Care; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Risk Adjustment; Rivaroxaban; Stroke	2021
Rationale and Design for a Randomized Comparison of Efficacy and Safety between Aspirin and Clopidogrel in Atrial Fibrillation Patients with Low Stroke Risk: CESAC-AF trial. Contemporary clinical trials, 2017, Volume: 60 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Endoscopy, Digestive System; Gastrointestinal Hemorrhage; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Research Design; Risk Factors; Stroke; Ticlopidine	2017
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation. The New England journal of medicine, 2017, 10-19, Volume: 377, Issue:16 Topics: Adenosine; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Risk; Ticagrelor; Ticlopidine; Warfarin	2017
Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). The American journal of cardiology, 2018, 03-01, Volume: 121, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Aspirin; Atrial Fibrillation; Clopidogrel; Female; Humans; Irbesartan; Male; Middle Aged; Platelet Aggregation Inhibitors; Predictive Value of Tests	2018
Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort study. BMC cardiovascular disorders, 2018, 06-18, Volume: 18, Issue:1 Topics: Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; Blood Coagulation; Blood Platelets; Cell Adhesion Molecules; Clopidogrel; Coronary Artery Disease; Drug Monitoring; Female; Hemorrhage; Humans; International Normalized Ratio; Male; Microfilament Proteins; Middle Aged; Percutaneous Coronary Intervention; Phosphoproteins; Platelet Aggregation; Platelet Aggregation Inhibitors; Predictive Value of Tests; Prospective Studies; Risk Factors; Time Factors; Treatment Outcome	2018
Risk of intracranial hemorrhage (RICH) in users of oral antithrombotic drugs: Nationwide pharmacoepidemiological study. PloS one, 2018, Volume: 13, Issue:8 Topics: Adolescent; Adult; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Norway; Pharmacoepidemiology; Risk Factors; Rivaroxaban; Thrombosis; Warfarin	2018
Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial. European heart journal, 2019, 05-14, Volume: 40, Issue:19 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Dual Anti-Platelet Therapy; Elective Surgical Procedures; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Ticagrelor; Warfarin	2019
Relationship of stroke and bleeding risk profiles to efficacy and safety of dabigatran dual therapy versus warfarin triple therapy in atrial fibrillation after percutaneous coronary intervention: An ancillary analysis from the RE-DUAL PCI trial. American heart journal, 2019, Volume: 212 Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Equivalence Trials as Topic; Female; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Risk Assessment; Stroke; Thromboembolism; Ticagrelor; Warfarin	2019
Antithrombotic treatment gap among patients with atrial fibrillation and type 2 diabetes. International journal of cardiology, 2019, 08-15, Volume: 289 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Platelet Aggregation Inhibitors; Sitagliptin Phosphate; Stroke; Time Factors; Treatment Outcome; Vitamin K	2019
Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial. Journal of the American College of Cardiology, 2019, 08-20, Volume: 74, Issue:7 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Carotid Artery, Common; Clopidogrel; Embolic Protection Devices; Female; Fibrinolytic Agents; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Pulmonary Embolism; Stroke; Thromboembolism; Ultrasonography, Interventional	2019
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial. European heart journal, 2014, Volume: 35, Issue:4 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Embolism; Female; Humans; Kaplan-Meier Estimate; Male; Morpholines; Myocardial Infarction; Platelet Aggregation Inhibitors; Pyridines; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin	2014
One-year outcome of patients with atrial fibrillation undergoing coronary artery stenting: an analysis of the AFCAS registry. Clinical cardiology, 2014, Volume: 37, Issue:6 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Female; Fibrinolytic Agents; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stents; Ticlopidine; Vitamin K	2014
Rationale and design of MANJUSRI trial: a randomized, open-label, active-controlled multicenter study to evaluate the safety of combined therapy with ticagrelor and warfarin in AF subjects after PCI-eS. Contemporary clinical trials, 2015, Volume: 40 Topics: Adenosine; Adolescent; Adult; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies; Research Design; Ticagrelor; Ticlopidine; Warfarin; Young Adult	2015
Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure. Stroke, 2015, Volume: 46, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Female; Heart Failure; Humans; Irbesartan; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Tetrazoles; Thromboembolism; Ticlopidine; Treatment Outcome; Ventricular Dysfunction, Left	2015
An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary intervention American heart journal, 2015, Volume: 169, Issue:4 Topics: Administration, Oral; Aged; Atrial Fibrillation; Clopidogrel; Coronary Angiography; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electrocardiography; Factor Xa Inhibitors; Female; Follow-Up Studies; Humans; Male; Middle Aged; Morpholines; Myocardial Ischemia; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Rivaroxaban; Thiophenes; Ticlopidine; Treatment Outcome; Vitamin K	2015
Rationale and design of the RT-AF study: Combination of rivaroxaban and ticagrelor in patients with atrial fibrillation and coronary artery disease undergoing percutaneous coronary intervention. Contemporary clinical trials, 2015, Volume: 43 Topics: Adenosine; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Hemorrhage; Humans; Percutaneous Coronary Intervention; Research Design; Rivaroxaban; Ticagrelor; Ticlopidine; Warfarin	2015
Impact of Dabigatran versus Phenprocoumon on ADP Induced Platelet Aggregation in Patients with Atrial Fibrillation with or without Concomitant Clopidogrel Therapy (the Dabi-ADP-1 and Dabi-ADP-2 Trials). BioMed research international, 2015, Volume: 2015 Topics: Adenosine Diphosphate; Administration, Oral; Aged; Aged, 80 and over; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Follow-Up Studies; Humans; Male; Middle Aged; Phenprocoumon; Platelet Aggregation; Ticlopidine	2015
Rationale and design of the SAFE-A study: SAFety and Effectiveness trial of Apixaban use in association with dual antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention. Journal of cardiology, 2017, Volume: 69, Issue:4 Topics: Aspirin; Atrial Fibrillation; Blood Transfusion; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridones; Stroke; Ticlopidine	2017
Dual Antiplatelet Therapy and Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndromes Managed Medically Without Revascularization: Insights From the TRILOGY ACS Trial. Clinical cardiology, 2016, Volume: 39, Issue:9 Topics: Acute Coronary Syndrome; Aged; Aspirin; Atrial Fibrillation; Chi-Square Distribution; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Female; Hemorrhage; Humans; Kaplan-Meier Estimate; Linear Models; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Prasugrel Hydrochloride; Proportional Hazards Models; Prospective Studies; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome	2016
Benefit of oral anticoagulant over antiplatelet therapy in atrial fibrillation depends on the quality of international normalized ratio control achieved by centers and countries as measured by time in therapeutic range. Circulation, 2008, Nov-11, Volume: 118, Issue:20 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brazil; Clopidogrel; Drug Therapy, Combination; Europe; Humans; International Normalized Ratio; Middle Aged; North America; Platelet Aggregation Inhibitors; Quality Control; South Africa; Ticlopidine; Time Factors; Treatment Outcome	2008
Effect of clopidogrel added to aspirin in patients with atrial fibrillation. The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vascular Diseases; Vitamin K	2009
[Clopidogrel in the treatment of atrial fibrillation: benefit from addition to aspirin. The results of ACTIVE A trial]. Kardiologiia, 2009, Volume: 49, Issue:5 Topics: Age Factors; Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Follow-Up Studies; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Russia; Stroke; Survival Rate; Ticlopidine; Treatment Outcome	2009
Mortality predictors and effects of antithrombotic therapies in atrial fibrillation: insights from ACTIVE-W. European heart journal, 2010, Volume: 31, Issue:17 Topics: Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Irbesartan; Kaplan-Meier Estimate; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Vitamin K	2010
Effects of CYP2C19 genotype on outcomes of clopidogrel treatment. The New England journal of medicine, 2010, Oct-28, Volume: 363, Issue:18 Topics: Acute Coronary Syndrome; Aged; Aryl Hydrocarbon Hydroxylases; Atrial Fibrillation; Clopidogrel; Cytochrome P-450 CYP2C19; Female; Genotype; Hemorrhage; Humans; Male; Middle Aged; Mutation; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2010
Net clinical benefit of adding clopidogrel to aspirin therapy in patients with atrial fibrillation for whom vitamin K antagonists are unsuitable. Annals of internal medicine, 2011, Nov-01, Volume: 155, Issue:9 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sensitivity and Specificity; Stroke; Ticlopidine; Vitamin K	2011
Incidence, predictors, and 30-day outcomes of new-onset atrial fibrillation after primary percutaneous coronary intervention: insight into the RISK-PCI trial. Coronary artery disease, 2012, Volume: 23, Issue:1 Topics: Aged; Angioplasty, Balloon, Coronary; Atrial Fibrillation; Chi-Square Distribution; Clopidogrel; Coronary Angiography; Coronary Artery Disease; Female; Hospital Mortality; Humans; Incidence; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Serbia; Ticlopidine; Time Factors; Treatment Outcome	2012
Effect of PON1 Q192R genetic polymorphism on clopidogrel efficacy and cardiovascular events in the Clopidogrel in the Unstable Angina to Prevent Recurrent Events trial and the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascula Circulation. Cardiovascular genetics, 2012, Apr-01, Volume: 5, Issue:2 Topics: Adult; Aged; Angina, Unstable; Aryldialkylphosphatase; Atrial Fibrillation; Clopidogrel; Female; Humans; Male; Middle Aged; Polymorphism, Single Nucleotide; Risk Factors; Ticlopidine	2012
The CHA2DS2-VASc score identifies those patients with atrial fibrillation and a CHADS2 score of 1 who are unlikely to benefit from oral anticoagulant therapy. European heart journal, 2013, Volume: 34, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Risk Assessment; Severity of Illness Index; Stroke; Thromboembolism; Ticlopidine	2013
Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial. Circulation, 2013, Feb-12, Volume: 127, Issue:6 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Embolism; Female; Follow-Up Studies; Humans; Male; Prostheses and Implants; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2013
A prospective randomized trial of aspirin-clopidogrel combination therapy and dose-adjusted warfarin on indices of thrombogenesis and platelet activation in atrial fibrillation. Journal of the American College of Cardiology, 2002, Aug-07, Volume: 40, Issue:3 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Chronic Disease; Clopidogrel; Cross-Sectional Studies; Drug Therapy, Combination; Female; Fibrin Fibrinogen Degradation Products; Follow-Up Studies; Humans; International Normalized Ratio; Male; Middle Aged; P-Selectin; Peptide Fragments; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Prothrombin; Ticlopidine; Treatment Outcome; Warfarin	2002
Clopidogrel and warfarin: absence of interaction in patients receiving long-term anticoagulant therapy for non-valvular atrial fibrillation. Thrombosis and haemostasis, 2003, Volume: 89, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Interactions; Drug Therapy, Combination; Female; Humans; International Normalized Ratio; Male; Middle Aged; Stereoisomerism; Ticlopidine; Time Factors; Warfarin	2003
Short-term prevention of thromboembolic complications in patients with atrial fibrillation with aspirin plus clopidogrel: the Clopidogrel-Aspirin Atrial Fibrillation (CLAAF) pilot study. American heart journal, 2004, Volume: 148, Issue:1 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Bleeding Time; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Electric Countershock; Female; Humans; International Normalized Ratio; Male; Middle Aged; Pilot Projects; Platelet Aggregation Inhibitors; Thromboembolism; Thromboxane B2; Ticlopidine; Warfarin	2004
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial. Lancet (London, England), 2006, Jun-10, Volume: 367, Issue:9526 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Humans; International Normalized Ratio; Irbesartan; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Stroke; Tetrazoles; Ticlopidine	2006
Rationale and design of ACTIVE: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events. American heart journal, 2006, Volume: 151, Issue:6 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Double-Blind Method; Female; Humans; Irbesartan; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Research Design; Tetrazoles; Ticlopidine	2006
Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: an ACTIVE W Substudy. Journal of the American College of Cardiology, 2007, Nov-27, Volume: 50, Issue:22 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Humans; Incidence; Male; Middle Aged; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome	2007
Clopidogrel and aspirin versus aspirin alone for the prevention of stroke in patients with a history of atrial fibrillation: subgroup analysis of the CHARISMA randomized trial. Cerebrovascular diseases (Basel, Switzerland), 2008, Volume: 25, Issue:4 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Female; Humans; Male; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome	2008
Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke, 2008, Volume: 39, Issue:5 Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clinical Protocols; Clopidogrel; Drug Combinations; Drug Therapy, Combination; Female; Humans; Irbesartan; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin	2008

Other Studies

146 other study(ies) available for clopidogrel and Atrial Fibrillation

Article	Year
Antithrombotic strategy and its relationship with outcomes in patients with atrial fibrillation and chronic coronary syndrome. Journal of thrombosis and thrombolysis, 2022, Volume: 53, Issue:4 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Fibrinolytic Agents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Treatment Outcome	2022
Influence of Clinically Significant Genes on Antiplatelet Effect of Clopidogrel and Clinical Outcomes in Patients with Acute Coronary Syndrome and Atrial Fibrillation. Pharmacology, 2022, Volume: 107, Issue:3-4 Topics: Acute Coronary Syndrome; Aryldialkylphosphatase; Atrial Fibrillation; Clopidogrel; Cytochrome P-450 CYP2C19; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Receptors, Cell Surface; Ticlopidine; Treatment Outcome	2022
Implementation of pharmacogenomic clinical decision support for health systems: a cost-utility analysis. The pharmacogenomics journal, 2022, Volume: 22, Issue:3 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Cost-Benefit Analysis; Decision Support Systems, Clinical; Humans; Markov Chains; Middle Aged; Pharmacogenetics; Quality-Adjusted Life Years; Vitamin K Epoxide Reductases; Warfarin	2022
A rare cause of abdominal pain managed unconventionally: acute renal infarction caused by atrial fibrillation: a case report. Journal of medical case reports, 2022, Oct-19, Volume: 16, Issue:1 Topics: Abdominal Pain; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Diltiazem; Humans; Infarction; Male; Nitroglycerin; Platelet Aggregation Inhibitors; Thromboembolism; Thrombosis; Warfarin	2022
Platelet function testing in atrial fibrillation patients undergoing percutaneous coronary intervention. Journal of thrombosis and thrombolysis, 2023, Volume: 55, Issue:1 Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor; Treatment Outcome	2023
Ten-year trends in sex differences in cardiovascular risk factors, in-hospital management, and outcomes of ischemic stroke in China: Analyses of a nationwide serial cross-sectional survey from 2005 to 2015. International journal of stroke : official journal of the International Stroke Society, 2023, Volume: 18, Issue:7 Topics: Atrial Fibrillation; Cardiovascular Diseases; China; Clopidogrel; Cross-Sectional Studies; Female; Heart Disease Risk Factors; Hospital Mortality; Hospitals; Humans; Ischemic Stroke; Male; Risk Factors; Sex Characteristics; Sex Factors; Stroke	2023
Clinical impact of high platelet reactivity in patients with atrial fibrillation and concomitant percutaneous coronary intervention on dual or triple antithrombotic therapy. Journal of thrombosis and thrombolysis, 2023, Volume: 55, Issue:4 Topics: Atrial Fibrillation; Clopidogrel; Cytochrome P-450 CYP2C19; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors	2023
Dual antithrombotic therapy with oral anticoagulant and P2Y12 inhibitors in patients with atrial fibrillation after percutaneous coronary intervention. Journal of cardiology, 2023, Volume: 82, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Prospective Studies; Retrospective Studies	2023
Secondary right atrial thrombosis in three dogs: Antithrombotics therapy and echocardiographic follow-up. Veterinary medicine and science, 2023, Volume: 9, Issue:5 Topics: Animals; Atrial Fibrillation; Clopidogrel; Dog Diseases; Dogs; Echocardiography; Fibrinolytic Agents; Follow-Up Studies; Heart Atria; Heart Diseases; Rivaroxaban; Thrombosis	2023
Comparison of atrial fibrillation predictors in patients with acute coronary syndrome using ticagrelor or clopidogrel Turkish journal of medical sciences, 2019, 10-24, Volume: 49, Issue:5 Topics: Acute Coronary Syndrome; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Echocardiography, Doppler; Electrocardiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; ST Elevation Myocardial Infarction; Ticagrelor	2019
Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure. The American journal of cardiology, 2019, 12-15, Volume: 124, Issue:12 Topics: Administration, Oral; Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Cohort Studies; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Finland; Follow-Up Studies; Geriatric Assessment; Hospitals, University; Humans; Kaplan-Meier Estimate; Male; Platelet Aggregation Inhibitors; Postoperative Care; Registries; Retrospective Studies; Risk Assessment; Stroke; Time Factors; Treatment Outcome	2019
Comparison of the Effect of Age (< 75 Versus ≥ 75) on the Efficacy and Safety of Dual Therapy (Dabigatran + Clopidogrel or Ticagrelor) Versus Triple Therapy (Warfarin + Aspirin + Clopidogrel or Ticagrelor) in Patients With Atrial Fibrillation After Percut The American journal of cardiology, 2020, 03-01, Volume: 125, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Revascularization; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Stroke; Thromboembolism; Ticagrelor; Treatment Outcome; Warfarin	2020
[Antithrombotic Therapy in Patients with Acute Coronary Syndrome and Atrial Fibrillation]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:14 Topics: Acute Coronary Syndrome; Acute Disease; Aspirin; Atrial Fibrillation; Clopidogrel; Combined Modality Therapy; Cyclophosphamide; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Risk Factors; Rivaroxaban; Stents; Stroke; Vitamin K	2020
Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion. The American journal of cardiology, 2020, 11-01, Volume: 134 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiovascular Diseases; Clopidogrel; Dual Anti-Platelet Therapy; Embolism; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Prosthesis Implantation; Septal Occluder Device; Stroke; Thrombosis	2020
Platelets Promote Ang II (Angiotensin II)-Induced Atrial Fibrillation by Releasing TGF-β1 (Transforming Growth Factor-β1) and Interacting With Fibroblasts. Hypertension (Dallas, Tex. : 1979), 2020, Volume: 76, Issue:6 Topics: Angiotensin II; Animals; Atrial Fibrillation; Atrial Remodeling; Blood Platelets; Clopidogrel; Fibroblasts; Humans; Hypertension; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Platelet Activation; Platelet Aggregation Inhibitors; Transforming Growth Factor beta1	2020
Antithrombotic therapy according to baseline bleeding risk in patients with atrial fibrillation undergoing percutaneous coronary intervention: applying the PRECISE-DAPT score in RE-DUAL PCI. European heart journal. Cardiovascular pharmacotherapy, 2022, 05-05, Volume: 8, Issue:3 Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Ticagrelor	2022
RHEDAR study: Determination of the risk of gastrointestinal hemorrhage in treatment with dabigatran, acenocoumarol and rivaroxaban. Journal of gastroenterology and hepatology, 2021, Volume: 36, Issue:10 Topics: Acenocoumarol; Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Retrospective Studies; Rivaroxaban; Warfarin	2021
Prevalence, Management, and Long-Term (6-Year) Outcomes of Atrial Fibrillation Among Patients Receiving Drug-Eluting Coronary Stents. JACC. Cardiovascular interventions, 2017, 06-12, Volume: 10, Issue:11 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prevalence; Proportional Hazards Models; Republic of Korea; Risk Factors; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2017
Use of oral anticoagulants in combination with antiplatelet(s) in atrial fibrillation. Heart (British Cardiac Society), 2018, Volume: 104, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Treatment Outcome; Vitamin K	2018
Thromboembolism after WATCHMAN Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2018, Volume: 92, Issue:1 Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Resistance; Drug Substitution; Echocardiography, Transesophageal; Female; Humans; Platelet Aggregation Inhibitors; Platelet Function Tests; Predictive Value of Tests; Risk Factors; Thromboembolism; Time Factors; Treatment Outcome; Warfarin	2018
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy? Herz, 2018, Volume: 43, Issue:1 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Guideline Adherence; Hemorrhage; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Randomized Controlled Trials as Topic; Risk Factors; Stents; Stroke; Thrombosis; Vitamin K	2018
Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:3 Topics: Acute Coronary Syndrome; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Blood Platelets; Clopidogrel; Cohort Studies; Coronary Angiography; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Incidence; Ischemia; Kaplan-Meier Estimate; Male; Middle Aged; Outcome Assessment, Health Care; Patient Safety; Phenindione; Propensity Score; Proportional Hazards Models; Risk; Treatment Outcome; Vitamin K	2018
Dual antiplatelet therapy is safe and efficient after left atrial appendage closure. Kardiologia polska, 2018, Volume: 76, Issue:2 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Patient Safety; Platelet Aggregation Inhibitors; Stroke; Treatment Outcome	2018
WATCHMAN device-related thrombus successfully treated with apixaban: A case report. Medicine, 2017, Volume: 96, Issue:47 Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Factor Xa Inhibitors; Humans; Male; Prostheses and Implants; Pyrazoles; Pyridones; Thrombosis; Ticlopidine	2017
Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2018, 04-06, Volume: 13, Issue:18 Topics: Age Factors; Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Administration Schedule; Drug Therapy, Combination; Echocardiography, Transesophageal; Feasibility Studies; Female; Germany; Hemorrhage; Humans; Incidence; Kidney; Kidney Diseases; Male; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stroke; Time Factors; Treatment Outcome	2018
Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug. Acta cardiologica, 2019, Volume: 74, Issue:1 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Male; Platelet Aggregation Inhibitors; Registries; Retrospective Studies; Risk Factors; Septal Occluder Device; Thromboembolism; Time Factors; Treatment Outcome	2019
Left ventricular mural thrombus despite treatment with dabigatran and clopidogrel. BMJ case reports, 2018, May-30, Volume: 2018 Topics: Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diagnosis, Differential; Drug Therapy, Combination; Dyspnea; Echocardiography; Fatal Outcome; Heart Diseases; Heart Failure; Humans; Male; Thrombosis; Ticlopidine; Warfarin	2018
Combining Oral Anticoagulants With Platelet Inhibitors in Patients With Atrial Fibrillation and Coronary Disease. Journal of the American College of Cardiology, 2018, 10-09, Volume: 72, Issue:15 Topics: Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Registries; Risk Assessment; Stroke; Warfarin	2018
Antiplatelet effects of aspirin and clopidogrel after left atrial appendage (LAA) occluder implantation. International journal of cardiology, 2019, Jan-15, Volume: 275 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Dose-Response Relationship, Drug; Drug Therapy, Combination; Echocardiography, Transesophageal; Female; Follow-Up Studies; Humans; Male; Pilot Projects; Platelet Aggregation; Platelet Aggregation Inhibitors; Postoperative Period; Retrospective Studies; Septal Occluder Device; Stroke; Treatment Outcome	2019
Atrial fibrillation, with ACS and PCI: walking a tightrope. European heart journal, 2019, 05-14, Volume: 40, Issue:19 Topics: Acute Coronary Syndrome; Atrial Fibrillation; Clopidogrel; Dabigatran; Humans; Percutaneous Coronary Intervention; Ticagrelor	2019
[Percutaneous left atrial appendage closure in a patient with atrial fibrillation and Rendu-Osler-Weber disease]. Giornale italiano di cardiologia (2006), 2019, Volume: 20, Issue:4 Suppl 1 Topics: Aged; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Echocardiography; Female; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Telangiectasia, Hereditary Hemorrhagic	2019
A prospective interventional registry of short-term dual-antiplatelet treatment after implantation of drug-eluting stents in patients with atrial fibrillation requiring oral anticoagulation therapy. Cardiovascular intervention and therapeutics, 2020, Volume: 35, Issue:2 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug-Eluting Stents; Dual Anti-Platelet Therapy; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Registries	2020
Stroke and transient ischemic attacks related to antiplatelet or warfarin interruption. Arquivos de neuro-psiquiatria, 2019, 07-29, Volume: 77, Issue:7 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brazil; Clopidogrel; Cross-Sectional Studies; Female; Humans; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Warfarin	2019
Thromboembolic events around the time of cardioversion for atrial fibrillation in patients receiving antiplatelet treatment in the ACTIVE trials. European heart journal, 2019, 09-21, Volume: 40, Issue:36 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Electric Countershock; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk; Thromboembolism	2019
Amplatzer left atrial appendage occlusion: single center 10-year experience. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2013, Aug-01, Volume: 82, Issue:2 Topics: Aged; Aged, 80 and over; Anesthesia, Local; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Radiography, Interventional; Retrospective Studies; Stroke; Switzerland; Ticlopidine; Time Factors; Treatment Outcome	2013
PCI patients taking oral anticoagulants may not need aspirin. BMJ (Clinical research ed.), 2013, Feb-20, Volume: 346 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Drug Therapy, Combination; Humans; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Ticlopidine; Treatment Outcome	2013
[Your patient needs antithrombotics, 2. What do the new substances offer? (interview by Dr. med. Peter Stiefelhagen)]. MMW Fortschritte der Medizin, 2013, Feb-21, Volume: 155, Issue:3 Topics: Adenosine; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Clopidogrel; Dabigatran; Fibrinolytic Agents; Guideline Adherence; Humans; Morpholines; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Thiophenes; Thromboembolism; Ticagrelor; Ticlopidine; Treatment Outcome	2013
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary intervention. Journal of the American College of Cardiology, 2013, Sep-10, Volume: 62, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Denmark; Drug Therapy, Combination; Female; Humans; Incidence; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Postoperative Complications; Registries; Risk Factors; Ticlopidine; Treatment Outcome	2013
Long-term safety and efficacy of dual therapy with oral anticoagulation and clopidogrel in patients with atrial fibrillation treated with drug-eluting stents. Clinical research in cardiology : official journal of the German Cardiac Society, 2013, Volume: 102, Issue:11 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Female; Follow-Up Studies; Hemorrhage; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome	2013
Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry. Circulation, 2013, Aug-13, Volume: 128, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebrovascular Disorders; Clopidogrel; Comorbidity; Dabigatran; Drug Synergism; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Models, Cardiovascular; Myocardial Ischemia; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Risk; Ticlopidine; Treatment Outcome	2013
The place of newer oral anticoagulants in the treatment of patients with non-valvular atrial fibrillation and coronary artery disease. International journal of clinical practice, 2013, Volume: 67, Issue:8 Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine	2013
Efficacy and safety of aspirin, clopidogrel, and warfarin after coronary artery stenting in Korean patients with atrial fibrillation. Heart and vessels, 2014, Volume: 29, Issue:5 Topics: Aged; Anticoagulants; Asian People; Aspirin; Atrial Fibrillation; Blood Coagulation; Clopidogrel; Coronary Artery Disease; Coronary Thrombosis; Disease-Free Survival; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; International Normalized Ratio; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Stents; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2014
Cost-effectiveness of different strategies for stroke prevention in patients with atrial fibrillation in a health resource-limited setting. Cardiovascular drugs and therapy, 2014, Volume: 28, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; China; Clopidogrel; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; Models, Economic; Morpholines; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Ticlopidine; Warfarin	2014
Bleeding risk with triple antithrombotic therapy in patients with atrial fibrillation and drug-eluting stents. Cardiovascular intervention and therapeutics, 2014, Volume: 29, Issue:3 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Stroke; Thienopyridines; Ticlopidine; Warfarin	2014
Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study. Circulation, 2014, Apr-15, Volume: 129, Issue:15 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Phenprocoumon; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Vitamin K; Warfarin	2014
Lower gastrointestinal bleeding associated with diclofenac topical patch in a patient with colonic mass and on antiplatelet therapy for atrial fibrillation. American journal of physical medicine & rehabilitation, 2014, Volume: 93, Issue:11 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Atrial Fibrillation; Clopidogrel; Colonic Neoplasms; Colonoscopy; Diclofenac; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Myofascial Pain Syndromes; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Transdermal Patch	2014
Intracranial hemorrhage during dual antiplatelet therapy after percutaneous left atrial appendage closure. Cerebrovascular diseases (Basel, Switzerland), 2014, Volume: 38, Issue:1 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2014
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation. The Canadian journal of cardiology, 2014, Volume: 30, Issue:10 Topics: Algorithms; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Canada; Clopidogrel; Comorbidity; Dabigatran; Electric Countershock; Humans; Renal Insufficiency, Chronic; Risk Assessment; Stroke; Ticlopidine	2014
Optimising pharmacotherapy for secondary prevention of non-invasively managed acute coronary syndrome. The Medical journal of Australia, 2014, Nov-17, Volume: 201, Issue:10 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticholesteremic Agents; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Fibrinolytic Agents; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Secondary Prevention; Ticlopidine	2014
Concomitant use of warfarin and ticagrelor as an alternative to triple antithrombotic therapy after an acute coronary syndrome. Thrombosis research, 2015, Volume: 135, Issue:1 Topics: Acute Coronary Syndrome; Adenosine; Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Retrospective Studies; Risk Factors; Thrombosis; Ticagrelor; Ticlopidine; Treatment Outcome; Warfarin	2015
[Paroxysmal atrial fibrillation well controlled. Why the sudden patient syncope?]. MMW Fortschritte der Medizin, 2015, Feb-05, Volume: 157, Issue:2 Topics: Amiodarone; Atrial Fibrillation; Clopidogrel; Coronary Disease; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Humans; Long QT Syndrome; Male; Middle Aged; Risk Factors; Syncope; Ticlopidine; Torsades de Pointes	2015
Cilostazol may prevent cardioembolic stroke in patients undergoing antiplatelet therapy. Neurological research, 2015, Volume: 37, Issue:7 Topics: Aged; Aspirin; Atrial Fibrillation; Cilostazol; Clopidogrel; Databases, Factual; Female; Fibrinolytic Agents; Humans; Incidence; Intracranial Embolism; Male; Multivariate Analysis; Platelet Aggregation Inhibitors; Retrospective Studies; Stroke; Tetrazoles; Ticlopidine	2015
Effect of Active Smoking on Comparative Efficacy of Antithrombotic Therapy in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project. Chest, 2015, Volume: 148, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Female; Hemorrhage; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Smoking; Stroke; Thromboembolism; Ticlopidine; Warfarin	2015
Antithrombotic therapy in patients undergoing TAVI with concurrent atrial fibrillation. One center experience. Journal of thrombosis and thrombolysis, 2015, Volume: 40, Issue:2 Topics: Acenocoumarol; Aged; Aged, 80 and over; Aortic Valve Stenosis; Atrial Fibrillation; Clopidogrel; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Ticlopidine; Transcatheter Aortic Valve Replacement	2015
Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage. JAMA ophthalmology, 2015, Volume: 133, Issue:10 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Clopidogrel; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Ticlopidine; Visual Acuity; Vitreous Hemorrhage; Warfarin	2015
[SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS]. Harefuah, 2015, Volume: 154, Issue:5 Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Atrial Fibrillation; Cardiology Service, Hospital; Clopidogrel; Female; Hospital Departments; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Israel; Male; Medication Therapy Management; Middle Aged; Patient Discharge; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Practice Patterns, Physicians'; Retrospective Studies; Secondary Prevention; Ticlopidine	2015
Anti-platelet pre-treatment for atrial fibrillation patients on warfarin referred for coronary angiography/stenting because of non-ST-elevation acute coronary syndrome: An alternative proposal. International journal of cardiology, 2015, Dec-15, Volume: 201 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Atrial Fibrillation; Clopidogrel; Coronary Angiography; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Warfarin	2015
Underutilisation of Guideline-based Therapy Primary Prevention among Patients Presenting with AF-related Ischaemic Stroke. Annals of the Academy of Medicine, Singapore, 2015, Volume: 44, Issue:7 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Dabigatran; Dipyridamole; Female; Guideline Adherence; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Ticlopidine; Warfarin	2015
A new approach: Left atrial appendage occlusion, as an alternative to anticoagulant, to treat patient who suffered of atrial fibrillation, acute coronary syndrome and clopidogrel resistance. International journal of cardiology, 2016, Jan-01, Volume: 202 Topics: Acute Coronary Syndrome; Aged; Anticoagulants; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Drug Resistance; Female; Humans; Radiography; Ticlopidine; Treatment Outcome; Ultrasonography	2016
Percutaneous left atrial appendage occlusion: Device thrombosis in clopidogrel non-responders. International journal of cardiology, 2016, Feb-01, Volume: 204 Topics: Aged; Aged, 80 and over; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Female; Heart Diseases; Humans; Male; Middle Aged; Prosthesis Implantation; Thrombosis; Ticlopidine; Treatment Outcome; Ultrasonography	2016
Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease. The American journal of medicine, 2016, Volume: 129, Issue:6 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hospitalization; Humans; Male; Markov Chains; Monte Carlo Method; Myocardial Infarction; Outcome and Process Assessment, Health Care; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pyridines; Registries; Stroke; Ticlopidine; Warfarin	2016
Impact of Triple Therapy in Elderly Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. PloS one, 2016, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Female; Humans; Male; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Risk Factors; Ticlopidine	2016
Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2016, Volume: 18, Issue:7 Topics: Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Surgical Procedures; Clopidogrel; Contraindications; Cost-Benefit Analysis; Germany; Humans; Markov Chains; Models, Theoretical; Pyrazoles; Pyridones; Quality of Life; Quality-Adjusted Life Years; Stroke; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2016
Another side effect of ticagrelor: Atrial fibrillation. International journal of cardiology, 2016, Jun-01, Volume: 212 Topics: Adenosine; Aged; Angina, Unstable; Atrial Fibrillation; Clopidogrel; Humans; Male; Ticagrelor; Ticlopidine; Treatment Outcome	2016
Bleeding complications of triple antithrombotic therapy after percutaneous coronary interventions. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2017, Feb-01, Volume: 89, Issue:2 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Ohio; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2017
Locked Away: Percutaneous Closure of a Malignant Left Atrial Appendage to Constrain an Unresolvable Thrombus. Circulation. Arrhythmia and electrophysiology, 2016, Volume: 9, Issue:8 Topics: Aged; Aspirin; Atrial Appendage; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Combined Modality Therapy; Coronary Angiography; Echocardiography, Transesophageal; Factor Xa Inhibitors; Humans; Male; Platelet Aggregation Inhibitors; Rivaroxaban; Septal Occluder Device; Thrombosis; Ticlopidine; Vitamin K	2016
Antithrombotic Medication Use and Misuse Among Patients with Intracranial Hemorrhage: A 16-Year, Lebanese, Single-Center Experience. World neurosurgery, 2016, Volume: 95 Topics: Acenocoumarol; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Cerebral Hemorrhage; Clopidogrel; Coronary Artery Disease; Enoxaparin; Female; Fibrinolytic Agents; Humans; Inappropriate Prescribing; Intracranial Hemorrhages; Lebanon; Male; Middle Aged; Platelet Aggregation Inhibitors; Prescription Drug Misuse; Retrospective Studies; Risk Factors; Stroke; Ticlopidine; Warfarin; Young Adult	2016
Trends in antithrombotic therapy for atrial fibrillation: Data from the Veterans Health Administration Health System. American heart journal, 2016, Volume: 179 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Clopidogrel; Dabigatran; Diabetes Mellitus; Female; Guideline Adherence; Heart Failure; Humans; Hypertension; Ischemic Attack, Transient; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk; Risk Assessment; Stroke; Ticlopidine; United States; United States Department of Veterans Affairs; Warfarin	2016
Association between antithrombotic treatment and hemorrhagic stroke in patients with atrial fibrillation-a cohort study in primary care. European journal of clinical pharmacology, 2017, Volume: 73, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Female; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Health Care; Stroke; Sweden; Ticlopidine; Warfarin	2017
Percutaneous left atrial appendage closure followed by single antiplatelet therapy: Short- and mid-term outcomes. Archives of cardiovascular diseases, 2017, Volume: 110, Issue:4 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Appendage; Atrial Fibrillation; Cardiac Catheterization; Clopidogrel; Drug Administration Schedule; Female; France; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Prospective Studies; Registries; Stroke; Thrombosis; Ticlopidine; Time Factors; Tomography, X-Ray Computed; Treatment Outcome	2017
Ticagrelor, but not clopidogrel active metabolite, displays antithrombotic properties in the left atrial endocardium. European heart journal, 2017, Mar-21, Volume: 38, Issue:12 Topics: Adenosine; Antithrombins; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Endocardium; Heart Atria; Humans; Plasminogen Activator Inhibitor 1; Purinergic P2Y Receptor Antagonists; Thromboplastin; Ticagrelor; Ticlopidine; Tumor Necrosis Factor-alpha	2017
Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest, 2008, Volume: 134, Issue:3 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Risk Factors; Stents; Ticlopidine; Warfarin	2008
Anticoagulant and/or antiplatelet treatment in patients with atrial fibrillation after percutaneous coronary intervention. A single-center experience. Medizinische Klinik (Munich, Germany : 1983), 2008, Sep-15, Volume: 103, Issue:9 Topics: Aged; Aged, 80 and over; Analysis of Variance; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Chi-Square Distribution; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Platelet Aggregation Inhibitors; Retrospective Studies; Risk; Stents; Ticlopidine; Time Factors; Treatment Outcome	2008
The ACTIVE pursuit of stroke prevention in patients with atrial fibrillation. The New England journal of medicine, 2009, May-14, Volume: 360, Issue:20 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K	2009
ACTIVE A: balancing the benefits and risks of clopidogrel and aspirin. The Lancet. Neurology, 2009, Volume: 8, Issue:6 Topics: Aged; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Humans; Intracranial Hemorrhages; Male; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine	2009
[Clopidogrel in the treatment of atrial fibrillation: comparison with warfarin. The results of ACTIVE W trial]. Kardiologiia, 2009, Volume: 49, Issue:5 Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Middle Aged; Platelet Aggregation Inhibitors; Russia; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin	2009
Prevention of stroke in patients with atrial fibrillation. The Medical letter on drugs and therapeutics, 2009, Jun-01, Volume: 51, Issue:1313 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Middle Aged; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Treatment Outcome; Vitamin K; Warfarin	2009
[Cardiology 2009]. Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:25-26 Topics: Aryl Hydrocarbon Hydroxylases; Atrial Fibrillation; Cardiology; Cardiovascular Diseases; Clopidogrel; Cytochrome P-450 CYP2C19; Exercise; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Platelet Aggregation Inhibitors; Polymorphism, Genetic; Stroke Volume; Ticlopidine	2009
[ASS plus clopidogrel in contraindication for marcumar]. MMW Fortschritte der Medizin, 2009, Apr-16, Volume: 151, Issue:16 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Intracranial Embolism; Phenprocoumon; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Ticlopidine	2009
Who is ineligible for warfarin in atrial fibrillation? Lancet (London, England), 2009, Aug-15, Volume: 374, Issue:9689 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Patient Selection; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Contraindications; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Embolism; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vascular Diseases	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Costs; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Risk; Stroke; Ticlopidine	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine; Vitamin K	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Incidence; Platelet Aggregation Inhibitors; Risk; Stroke; Ticlopidine; Vitamin K; Warfarin	2009
Clopidogrel plus aspirin in atrial fibrillation. The New England journal of medicine, 2009, Sep-24, Volume: 361, Issue:13 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Interactions; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Stroke; Ticlopidine	2009
Patient characteristics associated with the choice of triple antithrombotic therapy in acute coronary syndromes. The American journal of cardiology, 2009, Nov-01, Volume: 104, Issue:9 Topics: Acute Coronary Syndrome; Aged; Anemia; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Clopidogrel; Diabetes Mellitus; Drug Therapy, Combination; Drug Utilization; Female; Humans; Logistic Models; Male; Middle Aged; Patient Discharge; Platelet Aggregation Inhibitors; Registries; Smoking; Stents; Stroke; Stroke Volume; Ticlopidine; United States; Warfarin	2009
Pro: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Thrombosis and haemostasis, 2009, Volume: 102, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; International Normalized Ratio; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Warfarin	2009
Contra: "Anti-platelet therapy is an alternative to oral anticoagulation for atrial fibrillation". Thrombosis and haemostasis, 2009, Volume: 102, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Contraindications; Drug Therapy, Combination; Hemorrhage; Humans; Intracranial Embolism; Middle Aged; Multicenter Studies as Topic; Platelet Aggregation Inhibitors; Risk Factors; Severity of Illness Index; Thrombophilia; Ticlopidine; Vitamin K; Warfarin	2009
By the way, doctor. I am currently on Coumadin because I had atrial fibrillation after my bypass, Plavix because of my stent, and a baby aspirin. Why do I need to take three blood thinners? Harvard health letter, 2009, Volume: 34, Issue:12 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiopulmonary Bypass; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin	2009
Aspirin gets a backup against atrial fibrillation. Harvard heart letter : from Harvard Medical School, 2009, Volume: 19, Issue:11 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2009
Antiplatelet drugs for patients at high cardiovascular risk. Aspirin generally remains the best choice. Prescrire international, 2009, Volume: 18, Issue:104 Topics: Angina Pectoris; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Brain Ischemia; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Humans; Myocardial Infarction; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Risk; Stents; Stroke; Thromboembolism; Thrombosis; Ticlopidine; Warfarin	2009
[Abdominal tumor after persistent coughing and uncontrolled anticoagulation]. Praxis, 2010, Jan-06, Volume: 99, Issue:1 Topics: Abdomen, Acute; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Colonic Pseudo-Obstruction; Comorbidity; Cough; Dalteparin; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Hematoma; Humans; Intracranial Embolism; Phenprocoumon; Rectus Abdominis; Ticlopidine	2010
Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2010, May-01, Volume: 75, Issue:6 Topics: Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Humans; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Ticlopidine	2010
[Cardiac workup after cerebral ischemia. Consensus paper of the Working Group on Heart and Brain of the German Cardiac Society and German Stroke Society]. Der Nervenarzt, 2010, Volume: 81, Issue:4 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Clopidogrel; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Embolism; Exercise Test; Humans; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine; Warfarin	2010
Comparison of different antithrombotic regimens for patients with atrial fibrillation undergoing drug-eluting stent implantation. Circulation journal : official journal of the Japanese Circulation Society, 2010, Volume: 74, Issue:4 Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Drug-Eluting Stents; Female; Fibrinolytic Agents; Follow-Up Studies; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Prospective Studies; Risk Factors; Stroke; Thromboembolism; Ticlopidine; Treatment Outcome; Warfarin	2010
[Balancing act in antithrombotic therapy. Between hemorrhage and embolism]. MMW Fortschritte der Medizin, 2010, Mar-25, Volume: 152, Issue:12 Topics: Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Disease; Coronary Restenosis; Drug Interactions; Drug Therapy, Combination; Fibrinolytic Agents; Hemorrhage; Humans; Phenprocoumon; Proton Pump Inhibitors; Stents; Thromboembolism; Ticlopidine	2010
Role of triple antithrombotic therapy in patients with atrial fibrillation and coronary artery stents. The Medical journal of Australia, 2010, May-03, Volume: 192, Issue:9 Topics: Algorithms; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Vessels; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Management; Stents; Ticlopidine; Warfarin	2010
[Perioperative use of antithrombotic agents: recommendations of the American College of Chest Physicians (ACCP) and the French Superior Health Authority (HAS)]. Journal des maladies vasculaires, 2010, Volume: 35, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Cardiac Surgical Procedures; Clopidogrel; Fibrinolytic Agents; France; Heart Valve Prosthesis Implantation; Heparin; Heparin, Low-Molecular-Weight; Humans; Platelet Aggregation Inhibitors; Risk Factors; Societies, Medical; Ticlopidine; United States	2010
Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation. Archives of internal medicine, 2010, Sep-13, Volume: 170, Issue:16 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Hemorrhage; Humans; Incidence; Male; Proportional Hazards Models; Registries; Risk; Stroke; Ticlopidine; Warfarin	2010
Ischaemic stroke--prevention is better than cure. The journal of the Royal College of Physicians of Edinburgh, 2010, Volume: 40, Issue:1 Topics: Adult; Age Factors; Aged; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Blood Glucose; Cholesterol; Clopidogrel; Confidence Intervals; Decompression, Surgical; Endarterectomy, Carotid; Fibrinolytic Agents; Glycated Hemoglobin; Humans; Incidence; Middle Aged; Platelet Aggregation Inhibitors; Prevalence; Randomized Controlled Trials as Topic; Recurrence; Risk Factors; Smoking Cessation; Stroke; Ticlopidine	2010
CYP2C19 genotype and outcomes of clopidogrel treatment. The New England journal of medicine, 2011, 02-03, Volume: 364, Issue:5 Topics: Acute Coronary Syndrome; Aryl Hydrocarbon Hydroxylases; Atrial Fibrillation; Clopidogrel; Cytochrome P-450 CYP2C19; Genotype; Humans; Mutation; Platelet Aggregation Inhibitors; Risk Factors; Ticlopidine	2011
Atrial fibrillation, is warfarin the only option for stroke prevention? JPMA. The Journal of the Pakistan Medical Association, 2011, Volume: 61, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials as Topic; Clopidogrel; Evidence-Based Medicine; Humans; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin	2011
Atrial fibrillation, is warfarin the only option for stroke prevention? JPMA. The Journal of the Pakistan Medical Association, 2011, Volume: 61, Issue:4 Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Cerebral Hemorrhage; Clopidogrel; Evidence-Based Medicine; Follow-Up Studies; Humans; Hypertension; Irbesartan; Platelet Aggregation Inhibitors; Stroke; Tetrazoles; Ticlopidine; Treatment Outcome; Warfarin	2011
Dual antiplatelet therapy and the risk of bleeding. Archives of internal medicine, 2011, Apr-25, Volume: 171, Issue:8 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Drug-Eluting Stents; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Thrombosis; Ticlopidine; Warfarin	2011
The unmet need of patients with atrial fibrillation: AVERROES and the novel oral anticoagulants. International journal of stroke : official journal of the International Stroke Society, 2011, Volume: 6, Issue:3 Topics: Angiotensin II Type 1 Receptor Blockers; Anticoagulants; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clinical Trials, Phase III as Topic; Clopidogrel; Factor Xa Inhibitors; Fibrinolytic Agents; Humans; Intracranial Hemorrhages; Irbesartan; Platelet Aggregation Inhibitors; Pyrazoles; Pyridones; Stroke; Tetrazoles; Ticlopidine	2011
Atrial fibrillation treatment update. South Dakota medicine : the journal of the South Dakota State Medical Association, 2011, Volume: 64, Issue:7 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Heart Rate; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Thromboembolism; Ticlopidine	2011
Antithrombotic therapy use at discharge and 1 year in patients with atrial fibrillation and acute stroke: results from the AVAIL Registry. Stroke, 2011, Volume: 42, Issue:12 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Registries; Risk Factors; Stroke; Ticlopidine; Warfarin	2011
Thrombus formation on a left atrial appendage closure device. Circulation, 2011, Oct-04, Volume: 124, Issue:14 Topics: Aged; Anticoagulants; Aspirin; Atrial Appendage; Atrial Fibrillation; Clopidogrel; Equipment Design; Heart Diseases; Heparin; Humans; Male; Postoperative Complications; Septal Occluder Device; Thrombophilia; Thrombosis; Ticlopidine; Ultrasonography	2011
Clinical update on nursing home medicine: 2011. Journal of the American Medical Directors Association, 2011, Volume: 12, Issue:9 Topics: Anti-Ulcer Agents; Anticoagulants; Atrial Fibrillation; Clopidogrel; Clostridioides difficile; Delirium; Diabetes Complications; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Fractures, Bone; Geriatric Nursing; Humans; Male; Nursing Homes; Omeprazole; Osteoporosis; Peptic Ulcer; Platelet Aggregation Inhibitors; Pneumonia, Bacterial; Polypharmacy; Proton Pump Inhibitors; Risk Factors; Ticlopidine; Warfarin; Weight Loss	2011
Selecting the optimal stroke prevention therapy in atrial fibrillation. Annals of internal medicine, 2011, Nov-01, Volume: 155, Issue:9 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2011
Antiplatelet and anticoagulant therapy in patients with gastrointestinal bleeding: an 86-year-old woman with peptic ulcer disease. JAMA, 2011, Dec-07, Volume: 306, Issue:21 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Drug Interactions; Female; Gastrointestinal Hemorrhage; Humans; Peptic Ulcer; Platelet Aggregation Inhibitors; Proton Pump Inhibitors; Ticlopidine; Warfarin	2011
Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable. The American journal of cardiology, 2012, Apr-01, Volume: 109, Issue:7 Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials as Topic; Clopidogrel; Cohort Studies; Computer Simulation; Cost-Benefit Analysis; Drug Therapy, Combination; Follow-Up Studies; Humans; Markov Chains; Medicare; Monte Carlo Method; Platelet Aggregation Inhibitors; Quality-Adjusted Life Years; Research Design; Risk Factors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; United States; Warfarin	2012
Warfarin use in nursing home residents: results from the 2004 national nursing home survey. The American journal of geriatric pharmacotherapy, 2012, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cross-Sectional Studies; Health Care Surveys; Humans; Middle Aged; Nursing Homes; Platelet Aggregation Inhibitors; Ticlopidine; United States; Warfarin	2012
[Pharmacoeconomic analysis of dabigatran etexilate effectiveness in patients with nonvalvular atrial fibrillation]. Kardiologiia, 2012, Volume: 52, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Blood Coagulation; Blood Coagulation Tests; Clopidogrel; Costs and Cost Analysis; Dabigatran; Humans; Insurance, Pharmaceutical Services; Models, Statistical; Outcome and Process Assessment, Health Care; Pyridines; Russia; Thromboembolism; Ticlopidine	2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 2012, Volume: 141, Issue:2 Suppl Topics: Administration, Oral; Anticoagulants; Aspirin; Atrial Fibrillation; Atrial Flutter; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Hemorrhage; Humans; International Normalized Ratio; Risk Factors; Societies, Medical; Stroke; Ticlopidine; Vitamin K	2012
Comparison of additional versus no additional heparin during therapeutic oral anticoagulation in patients undergoing percutaneous coronary intervention. The American journal of cardiology, 2012, Jul-01, Volume: 110, Issue:1 Topics: Administration, Oral; Aged; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Fibrinolytic Agents; Follow-Up Studies; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Postoperative Complications; Preoperative Care; Prospective Studies; Thrombosis; Ticlopidine; Time Factors; Treatment Outcome; Warfarin	2012
Paraoxonase 1 Q192R variant and clopidogrel efficacy: fact or fiction? Circulation. Cardiovascular genetics, 2012, Apr-01, Volume: 5, Issue:2 Topics: Angina, Unstable; Aryldialkylphosphatase; Atrial Fibrillation; Clopidogrel; Female; Humans; Male; Polymorphism, Single Nucleotide; Ticlopidine	2012
Triple antithrombotic therapy after coronary stenting in the elderly with atrial fibrillation: necessary or too hazardous? American heart journal, 2012, Volume: 163, Issue:4 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Stents; Ticlopidine; Warfarin	2012
Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction. American heart journal, 2012, Volume: 163, Issue:4 Topics: Aged; Aged, 80 and over; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Medicare; Myocardial Infarction; Patient Readmission; Proportional Hazards Models; Registries; Ticlopidine; Treatment Outcome; United States; Warfarin	2012
Clopidogrel in atrial fibrillation: is there any justification now in the era of new anticoagulants? The American journal of cardiology, 2012, Jul-01, Volume: 110, Issue:1 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Stroke; Ticlopidine	2012
Atrial fibrillation and acute myocardial infarction: antithrombotic therapy and outcomes. The American journal of medicine, 2012, Volume: 125, Issue:9 Topics: Adrenergic beta-Antagonists; Age Factors; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Comorbidity; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Patient Discharge; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Research Design; Risk Assessment; Stroke; Thiophenes; Ticlopidine; Treatment Outcome; Warfarin	2012
[Comparison of three methods of antithrombotic therapy in elderly patients with nonvalvular atrial fibrillation]. Kardiologiia, 2012, Volume: 52, Issue:7 Topics: Administration, Oral; Aged; Anticoagulants; Antithrombins; Aspirin; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Drug Monitoring; Drug Therapy, Combination; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Survival Rate; Ticlopidine; Treatment Outcome; Warfarin	2012
Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study. Circulation, 2012, Sep-04, Volume: 126, Issue:10 Topics: Acute Coronary Syndrome; Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Comorbidity; Denmark; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Registries; Risk Factors; Stroke; Ticlopidine; Vitamin K	2012
Antithrombotic therapy for atrial fibrillation and coronary artery disease in older patients. American heart journal, 2012, Volume: 164, Issue:4 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Diabetes Complications; Female; Fibrinolytic Agents; Heart Failure; Humans; Hypertension; Male; Risk Assessment; Stroke; Ticlopidine; Treatment Outcome; Warfarin	2012
[Expert answer. Coronary artery patients with atrial fibrillation on anticoagulation treatment may need antithrombotic treatment. What kind is there?]. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2012, Volume: 40, Issue:4 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Ticlopidine; Warfarin	2012
[Safety and efficacy of various modalities of antiplatelet prophylaxis of ischemic stroke in elderly patients with non-valvular atrial fibrillation]. Klinicheskaia meditsina, 2012, Volume: 90, Issue:10 Topics: Age Factors; Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Brain Ischemia; Clopidogrel; Dabigatran; Female; Hemorrhage; Humans; Male; Platelet Aggregation Inhibitors; Stroke; Thromboembolism; Ticlopidine; Warfarin	2012
The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thrombosis and haemostasis, 2013, Volume: 109, Issue:3 Topics: Aged; Atrial Fibrillation; Case-Control Studies; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fibrinolytic Agents; Hemorrhage; Humans; Male; Middle Aged; Regression Analysis; Risk Factors; Thrombosis; Ticlopidine; United Kingdom; Warfarin	2013
[Anticoagulation and antiaggregation in cardiac patients]. Therapeutische Umschau. Revue therapeutique, 2003, Volume: 60, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Cardiovascular Diseases; Clinical Trials as Topic; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Placebos; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Primary Prevention; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Thromboembolism; Ticlopidine	2003
Spontaneous pharyngeal haemorrhage in the anticoagulated patient. Irish medical journal, 2003, Volume: 96, Issue:2 Topics: Aged; Anticoagulants; Atrial Fibrillation; Clopidogrel; Hemorrhage; Humans; Male; Pharyngeal Diseases; Platelet Aggregation Inhibitors; Ticlopidine; Warfarin	2003
Elective coronary angiography and percutaneous coronary intervention during uninterrupted warfarin therapy. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2003, Volume: 60, Issue:2 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Atrial Fibrillation; Cardiac Catheterization; Cerebrovascular Disorders; Clopidogrel; Coronary Angiography; Coronary Disease; Equipment Design; Feasibility Studies; Female; Follow-Up Studies; Heart Failure; Heart Septal Defects, Atrial; Heart Valve Diseases; Humans; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Postoperative Complications; Ticlopidine; Treatment Outcome; Venous Thrombosis; Warfarin	2003
Proximal deep venous thrombosis occurring after sudden clopidogrel suspension. European journal of clinical pharmacology, 2004, Volume: 60, Issue:1 Topics: Aged; Atrial Fibrillation; Clopidogrel; Humans; Male; Platelet Aggregation Inhibitors; Prognosis; Substance Withdrawal Syndrome; Ticlopidine; Urticaria; Venous Thrombosis; Withholding Treatment	2004
Clopidogrel-aspirin combination for atrial fibrillation: CLAAF is not CLEAR. American heart journal, 2005, Volume: 149, Issue:1 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Clinical Trials, Phase II as Topic; Clopidogrel; Drug Therapy, Combination; Feasibility Studies; Humans; Pilot Projects; Platelet Aggregation Inhibitors; Research Design; Thromboembolism; Ticlopidine; Warfarin	2005
Clopidogrel as antithrombotic therapy in atrial fibrillation. Chest, 2005, Volume: 128, Issue:1 Topics: Atrial Fibrillation; Atrial Flutter; Clopidogrel; Electric Countershock; Evidence-Based Medicine; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Stroke; Ticlopidine; Vitamin K	2005
[Prophylaxis of stroke]. Praxis, 2005, Jul-27, Volume: 94, Issue:30-31 Topics: Age Factors; Aged; Angioplasty, Balloon; Anticoagulants; Antihypertensive Agents; Aspirin; Atrial Fibrillation; Brain Ischemia; Carotid Stenosis; Clopidogrel; Coronary Disease; Diabetes Mellitus; Diet; Drug Therapy, Combination; Endarterectomy, Carotid; Exercise; Female; Humans; Hypertension; Hypolipidemic Agents; Life Style; Male; Middle Aged; Platelet Aggregation Inhibitors; Primary Prevention; Risk Factors; Sex Factors; Smoking Cessation; Stents; Stroke; Ticlopidine; Time Factors	2005
[Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment]. MMW Fortschritte der Medizin, 2006, Apr-13, Volume: 148, Issue:15 Topics: Administration, Oral; Age Factors; Anti-Arrhythmia Agents; Anticoagulants; Aspirin; Atrial Fibrillation; Catheter Ablation; Clopidogrel; Drug Therapy, Combination; Fibrinolytic Agents; Germany; Humans; Middle Aged; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Registries; Risk Factors; Thromboembolism; Ticlopidine; Vitamin K	2006
Good old warfarin for stroke prevention in atrial fibrillation. Lancet (London, England), 2006, Jun-10, Volume: 367, Issue:9526 Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Drug Therapy, Combination; Hemorrhage; Humans; Platelet Aggregation Inhibitors; Risk Factors; Stroke; Ticlopidine; Warfarin	2006
Anticoagulant and antiplatelet therapy use in patients with atrial fibrillation undergoing percutaneous coronary intervention: the need for consensus and a management guideline. Chest, 2006, Volume: 130, Issue:6 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Combined Modality Therapy; Consensus Development Conferences as Topic; Coronary Stenosis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Heparin, Low-Molecular-Weight; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Practice Guidelines as Topic; Risk Factors; Stents; Stroke; Ticlopidine; Warfarin	2006
Prevention of vascular events in atrial fibrillation. Lancet (London, England), 2007, Jan-13, Volume: 369, Issue:9556 Topics: Accidental Falls; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Humans; Platelet Aggregation Inhibitors; Stroke; Ticlopidine	2007
Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy. Pharmacotherapy, 2007, Volume: 27, Issue:5 Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Anticoagulants; Aspirin; Atrial Fibrillation; Clopidogrel; Cohort Studies; Drug Interactions; Drug Therapy, Combination; Female; Follow-Up Studies; Hemorrhage; Humans; Incidence; International Normalized Ratio; Male; Middle Aged; Platelet Aggregation Inhibitors; Proportional Hazards Models; Retrospective Studies; Risk Factors; Ticlopidine; Warfarin	2007
[Anticoagulation in atrial fibrillation. ACTIVE Study (Arterial fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events)]. Der Internist, 2007, Volume: 48, Issue:8 Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Aspirin; Atrial Fibrillation; Biphenyl Compounds; Clopidogrel; Drug Therapy, Combination; Follow-Up Studies; Hemorrhage; Humans; Intracranial Embolism; Irbesartan; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Tetrazoles; Thromboembolism; Ticlopidine	2007
Triple antithrombotic therapy with aspirin, clopidogrel and warfarin--a persisting dilemma. Internal and emergency medicine, 2007, Volume: 2, Issue:3 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Coronary Thrombosis; Drug Therapy, Combination; Fibrinolytic Agents; Humans; Risk Factors; Ticlopidine; Venous Thrombosis; Warfarin	2007
Treatment in a haemophiliac A patient with paroxysmal atrial fibrillation and ischemic heart disease. Haemophilia : the official journal of the World Federation of Hemophilia, 2007, Volume: 13, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Clopidogrel; Follow-Up Studies; Hemophilia A; Heparin; HIV Infections; Humans; Male; Middle Aged; Myocardial Ischemia; Pacemaker, Artificial; Platelet Aggregation Inhibitors; Ticlopidine; Treatment Outcome	2007
Post-stenting antithrombotic drug therapy in patients with atrial fibrillation. The American journal of medicine, 2007, Volume: 120, Issue:11 Topics: Aspirin; Atrial Fibrillation; Clopidogrel; Fibrinolytic Agents; Humans; Practice Guidelines as Topic; Risk Factors; Stents; Thrombosis; Ticlopidine; Warfarin	2007
Clinical safety and efficacy of clopidogrel--implications of the Clopidogrel versus Aspirin in Patients at Risk of Ischemic Events (CAPRIE) study for future management of atherosclerotic disease. Clinical therapeutics, 1998, Volume: 20 Suppl B Topics: Arteriosclerosis; Aspirin; Atrial Fibrillation; Brain Ischemia; Clopidogrel; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Risk Factors; Ticlopidine; United States; Vascular Diseases	1998
Current strategies of secondary prevention after a cerebrovascular event: the Vienna stroke registry. Stroke, 2001, Dec-01, Volume: 32, Issue:12 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anticoagulants; Aspirin; Atrial Fibrillation; Austria; Clopidogrel; Cohort Studies; Comorbidity; Contraindications; Cross-Sectional Studies; Dipyridamole; Drug Combinations; Female; Humans; Intracranial Embolism; Ischemic Attack, Transient; Logistic Models; Male; Middle Aged; Multivariate Analysis; Platelet Aggregation Inhibitors; Registries; Secondary Prevention; Stroke; Ticlopidine	2001